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ABSTRACT
THE SPATIAL ORGANIZATION OF MYCOBACTERIAL MEMBRANE

MAY 2019
JULIA PUFFAL
B.S., CENTRO UNIVERSITARIO FEEVALE
M.S., PONTIFÍCIA UNIVERSIDADE CATÓLICA DO RIO GRANDE DO SUL
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor YASU S. MORITA
Mycobacteria comprises a large group of organisms including the pathogenic
species Mycobacterium tuberculosis, the causative agent of tuberculosis. A fastgrowing saprophytic member of this genus, however, Mycobacterium smegmatis, is
oftentimes used as a model organism for the pathogenic species. With a unique cell
envelope architecture and unconventional polar growth, spatial coordination of cell
envelope biosynthesis is vital for proper assembly of this complex structure. Here,
we provide a comprehensive overview of known lateral heterogeneities in
mycobacterial plasma membrane, with a particular focus on the intracellular
membrane domain (IMD), a spatially distinct region of the plasma membrane with
diverse functions. Besides harboring processes important for the cell envelope
biosynthesis, previous comparative proteomic analysis of the IMD suggested that
menaquinone biosynthetic enzymes are associated with this domain. In the present
study, we the confirmed the IMD-association of this biosynthesis in M. smegmatis.
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implying a previously unappreciated role of the IMD linked to the central
metabolism of mycobacteria. Finally, we show evidence that the same IMD exists in
M. tuberculosis in addition to the classical plasma membrane. Similar to M.
smegmatis, enzyme assays, western blotting, and proteomic analysis all indicated
enrichment of lipid metabolism and other reactions in the IMD of M. tuberculosis.
Taken together, these data indicate that functional compartmentalization of
membrane is a common feature found in both M. tuberculosis and M. smegmatis.
These observations support that the IMD is a conserved domain within bacteria
involved in a variety of cellular processes.
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CHAPTER 1
SPATIAL CONTROL OF CELL ENVELOPE BIOSYNTHESIS IN MYCOBACTERIA
(Previously published in whole in Pathogens and Disease in June 2018)

1. 1 A brief overview of cell envelope structure
The cell envelope is critical for mycobacteria to maintain cell shape, provide
a permeability barrier and modulate the host immune response. The biosynthetic
pathways and various aspects of its functional significance are discussed in other
chapters in this issue (by Jordi Torrelles and Jessica Seeliger) and other recent
reviews (Jackson 2014; Pavelka, Mahapatra and Crick 2014; Minnikin et al. 2015;
Jankute et al. 2015; Källenius et al. 2016; Alderwick et al. 2015).
The mycobacterial cell envelope is composed of five main layers: an outer
layer or capsule, the mycolic acid (MA)-rich outer membrane (OM) also known as
mycomembrane, the arabinogalactan (AG) layer, followed by the core peptidoglycan
(PG) sacculus and the plasma membrane (PM) (Fig. 1.1) (Minnikin 1982). The OM is
rich in glycans and lipids, including trehalose dimycolate, phthiocerol
dimycocerosate (PDIM), phenolic glycolipid (PGL), glycopeptidolipid (GPL),
triacylglycerol, diacylglycerol, lipomannan and lipoarabinomannan (Bansal-Mutalik
and Nikaido 2014; Jackson 2014; Jankute et al. 2015). Some of these lipids are
universally found in all Mycobacterium species, while some others such as GPLs,
PGLs and PDIMs are only present in select species, conferring species-specific
features (see reviews Daffé, Crick and Jackson 2014; Jackson 2014). The inner leaflet
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Figure 1.1. A model of mycobacterial cell envelope.
The model shows each layer as follows: the plasma membrane (PM), peptidoglycan
layer (PG), arabinogalactan (AG) layer and the outer membrane (OM). Major lipids
present in the PM and the OM are as indicated in the model, but do not represent the
true relative abundance. Some structural details of the lipids are omitted, and the
thickness of each layer is not to scale. Some lipids such as GPLs and PDIMs are
species-specific (see text for detail). GPL, glycopeptidolipid; LM, lipomannan; LAM,
lipoarabinomannan; TMM, trehalose monomycolate; TDM, trehalose dimycolate; PI,
phosphatidylinositol; CL, cardiolipin; PE, phosphatidylethanolamine; TAG, triacylglycerol; PDIM, phthiocerol dimycocerosate.
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of the OM is proposed to be composed primarily of MA that can be up to C90 in
length (Marrakchi, Lanéelle and Daffé 2014). These MAs are covalently linked to the
AG layer beneath, which is composed primarily of 5- and 6- linked β-dgalactofuranose (Galf) residues and arabinose chains (Angala et al. 2014; Jankute et
al. 2015). The AG is connected to the N-acetylmuramic acid residues of PG through
the alpha-l-rhamnose-1,3-d-GlcNAc-1-phosphate linker (McNeil, Daffé and Brennan
1990). The entire crosslinked layers of MA, AG and PG are often referred to as the
mycolyl-arabinogalactan-peptidoglycan (mAGP) complex.
Underneath the PG layer is the periplasmic space followed by the PM,
composed of major phospholipids such as phosphatidylethanolamine (PE),
cardiolipin (CL), phosphatidylinositol (PI) and phosphatidylinositol mannosides
(PIMs). Biosynthetic pathways of many cell envelope lipids and glycans start in the
cytoplasm or the cytoplasmic side of the PM, followed by reactions taking place in
the periplasmic space. For detailed metabolic reactions taking place in the PM,
readers are directed to our previous review (Crellin, Luo and Morita 2013). In the
current review, we will discuss the spatial coordination of the cell envelope
biosynthesis and other biological processes in mycobacteria and how PM
compartmentalization plays a role in these processes.

1.2 Spatial positioning of cell envelope biosynthetic machineries and other
membrane-bound proteins
Unlike other model eubacteria, mycobacteria and other actinobacteria
elongate the cell envelope by zonal growth at the cell poles. To support this localized
growth, cell envelope biosynthesis must take place in a spatially coordinated
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manner at the poles as well as the septum. The two poles are not equal. The polar
growth is asymmetric in that the growth from the old pole is faster than that from
the new pole (Aldridge et al. 2012). Recent work suggests that the asymmetric
growth is in fact a regulated process, as the divisome protein LamA negatively
regulates elongation at newly formed poles (Fig. 1.2) (Rego, Audette and Rubin
2017). Cells that lack this protein grow more evenly from both new and old poles,
and are interestingly more susceptible to killing by certain antibiotics (Rego,
Audette and Rubin 2017). In this section, we will discuss how the cell envelope
biosynthesis is coordinated spatially and will further highlight other cellular
processes that are spatially segregated.

1.2.1 PG biosynthesis occurs at the poles
Expansion of PG determines the rate of bacterial growth (Rojas, Huang and
Theriot 2017). Unlike model organisms such as Escherichia coli and Bacillus subtilis,
which elongate by inserting new PG along the sidewall (de Pedro et al. 1997; Daniel
and Errington 2003), mycobacteria grow from the cell poles (Hett and Rubin 2008;
Aldridge et al. 2012). In support, fluorescent protein fusions to a variety of enzymes
involved in PG synthesis are preferentially enriched at the poles, including MurG
(Fig. 1.2), the synthase for the membrane-linked precursor lipid II (Meniche et al.
2014), as well as various transglycosylases and transpeptidases that respectively
stitch together the glycan and peptide to create the mature PG (Hett, Chao and
Rubin 2010; Plocinski et al. 2011; Kieser et al. 2015; Viswanathan et al. 2017). These
studies are supported by experiments that examined the localization of PG itself.
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Figure 1.2. Overview of protein localization during cell growth.
The divisome is assembled at the midcell driven by the formation of an FtsZ ring
interacting with various proteins. DivIVA orchestrate the polar growth, interacting
with the Acc complex. MabA and InhA localize to the pole as well for MA
biosynthesis. ParA also interacts with DivIVA to ensure chromosomal DNA
segregation. While there are more than 300 IMD-associated proteins identified by
proteomic analysis, only some experimentally verified proteins are indicated. Exact
morphological configuration of the IMD is unknown, and depicted as a membrane
zone proximal to the polar DivIVA complex. See Fig. 1.3 for more IMD-associated
proteins. IMD, intracellular membrane domain. Z, FtsZ; W, FtsW; BLQ,
FtsB/FtsL/FtsQ.
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Indeed, one of the first pieces of evidence indicating this growth model was
the polar staining by a fluorescent conjugate of vancomycin, an antibiotic that binds
uncrosslinked PG at the sites of synthesis (Thanky, Young and Robertson 2007).
More recent bioorthogonal (click) metabolic labeling using structural analogs of PG
biosynthetic precursors, such as alkyne-functionalized d-Ala, or d-Ala-d-Ala, further
suggest that PG synthesis occurs at the poles of mycobacterial cells (Siegrist et al.
2013; Meniche et al. 2014; Boutte et al. 2016, 2017; Rodriguez-Rivera et al. 2017;
Schubert et al. 2017; Hayashi et al. 2018).

1.2.2 Spatially coincident synthesis of AG and OM at the polar ends
Given the covalently linked mAGP complex, assembly of these structures is
likely to be coordinated. This idea is supported by biochemical data showing that
ligation of AG to PG occurs only after the latter has been crosslinked by
transpeptidases (Hancock et al. 2002). Several lines of evidence suggest that
synthesis of mAGP occurs either at the same place or in close proximity within the
cell. First, antibiotics that target different layers cause the same morphological
defect, i.e. polar lysis (Bardou et al. 1996; Makarov et al. 2009; Kumar et al. 2012;
Botella et al. 2017). Second, fluorescent protein fusions to enzymes involved in the
cytoplasmic steps of AG and OM synthesis are preferentially enriched at the poles
(Carel et al. 2014; Meniche et al. 2014; Hayashi et al. 2016), and MmpL3, the
transporter for the trehalose monomycolate precursor, also dynamically localizes to
the growing poles in addition to its enrichment at the septa (Carel et al. 2014). To
our knowledge, localization of proteins involved in the extracellular steps of AG and
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OM synthesis has not yet been reported for mycobacteria. However, a fluorescent
protein fusion to the AG-transferring protein LcpA colocalizes with metabolically
labeled PG at the cell tips of the related species Corynebacterium glutamicum
(Baumgart et al. 2016). Furthermore, metabolic labeling experiments of the OM MA
suggest that the assembly is enriched at the poles of mycobacteria (Backus et al.
2011; Swarts et al. 2012; Foley et al. 2016). Taken together, these experiments
insinuate that the mAGP synthesis is likely to be spatially coincident or in close
proximity during elongation.

1.2.3 Cell envelope synthesis at the septum
Electron microscopy (EM) studies showed the formation of the
mycobacterial septum near the midcell (Takade et al. 1983; Vijay, Anand and
Ajitkumar 2012). However, the precise molecular constituents of the electrontransparent and electron-dense layers remain unclear, and the dynamics of division
must be inferred. Fluorescent labeling of both proteins and cell envelope precursors
have begun to fill these gaps. It is important to realize that the biogenesis of the
septum is a process to establish new poles for the daughter cells, and nearly all of
the biomolecules described above for polar growth appear to localize to the midcell
region as well. In mycobacteria, key PG biosynthetic enzymes, such as lipid II
synthase MurG, a putative SEDS family PG glycosyltransferase FtsW (Meeske et al.
2016) and transglycosylase/D,D-transpeptidases PBPA and PBPB (FtsI) are
members of the divisome (Fig. 1.2) (Datta et al. 2002; Rajagopalan et al. 2005b;
Datta et al. 2006; Plocinski et al. 2011) (see section ‘FtsZ, divisome, and division
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plane determination’ for more detail). These interactions are also essential in other
bacteria (Pinho and Errington 2003; Aaron et al. 2007; Mohammadi et al. 2007), and
recent studies point that PG synthesis is necessary for driving cytokinesis in E. coli
and B. subtilis, possibly by providing constriction force during the onset of septum
formation (Coltharp et al. 2016; Monteiro et al. 2018). Nevertheless, mycobacteria
also have distinct proteins that regulate septal envelope synthesis. The membranebound CwsA and CrgA ensure proper PG assembly by influencing the localization of
PBPs and DivIVA (Plocinski et al. 2011, 2012), and because DivIVA interacts with
enzymes responsible for MA biosynthesis (Meniche et al. 2014) (see below), it is
likely that these associations also drive septal MA production as illustrated by
metabolic labeling (Swarts et al. 2012; Foley et al. 2016). Importantly, the
coordinated activity of PG hydrolytic, modifying and synthetic enzymes localized to
the septum ensures proper separation of the mother cell PG into two daughter cells
(Chauhan et al. 2006; Hett et al. 2007, 2008; Hett, Chao and Rubin 2010; Vadrevu et
al. 2011; Senzani et al. 2017).

1.2.4 Other membrane-bound proteins with spatially restricted locations
In addition to cell envelope biosynthetic machineries localizing to restricted
regions, there are additional proteins that show spatial organizations within the
mycobacterial PM. Here we highlight some that are relevant to envelope
biosynthesis.
Signal transduction kinases show distinct localizations within mycobacterial
PM. Mycobacteria have a repertoire of Ser/Thr protein kinases. Among them, PknA
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and PknB localize at the poles and septum, and regulate enzymes involved in
synthesis of PG and other cell envelope components (Molle et al. 2006; Thakur and
Chakraborti 2006, 2008; Parikh et al. 2009; Mir et al. 2011; Gee et al. 2012; Baer et
al. 2014; Kieser et al. 2015). Other kinases (PknD, PknE, PknH, PknJ and PknL) also
localize at the poles and septum, but their contribution to envelope synthesis
remains less well-defined (Baer et al. 2014). Mycobacteria also utilize two
component regulatory systems albeit not as extensively as other bacteria. Among
them, MtrAB is the only system known to be essential, and the sensor kinase MtrB is
localized at the septum (Via et al. 1996; Zahrt and Deretic 2000; Plocinska et al.
2012). The response regulator MtrA activates genes involved in DNA replication,
drug resistance, and cell wall biogenesis (Fol et al. 2006; Li et al. 2010; Rajagopalan
et al. 2010; Plocinska et al. 2012; Purushotham et al. 2015), and the disruption of
the signaling pathway results in abnormal cell division, altered cell morphology and
increased cell wall permeability (Möker et al. 2004; Cangelosi et al. 2006; Nguyen et
al. 2010; Plocinska et al. 2012), implying its critical role in cell envelope
biosynthesis. More detailed discussion on these kinases can be found in recent
reviews (Parish 2014; Prisic and Husson 2014).
Another important mediator of bacterial signal transduction is cyclic
diguanosine monophosphate (c-di-GMP), a ubiquitous second messenger, which can
induce various physiological responses in the bacterial cell and community. In
mycobacteria, c-di-GMP is critical for survival during carbon starvation (Gupta,
Kumar and Chatterji 2010; Bharati et al. 2012; Bharati, Swetha and Chatterji 2013),
and downstream effectors include a number of proteins involved in regulating cell
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envelope metabolism (Li and He 2012; Deng et al. 2014; Zhang et al. 2017). DcpA, a
bifunctional diguanylate cyclase and phosphodiesterase, orchestrates the c-di-GMP
turnover, and localizes to the poles during early stationary phase (Sharma et al.
2014). Experimentally altering the DcpA levels affects cell length and colony
morphology of Mycobacterium smegmatis (Sharma et al. 2014), implicating the
importance of c-di-GMP signaling in controlling the cell division cycle and surface
architecture.
Fatty acid synthesis is critical for numerous aspects of the cell envelope
biogenesis. The initial stage of fatty acid synthesis is mediated by a multifunctional
cytoplasmic enzyme, FAS-I, which produces two populations of fatty acyl-CoA
carrying 16–18 or 24–26 carbons. The C acyl-CoA is further elongated by the FAS-II
system, leading to the production of the long meromycolate precursors. The β ketoacyl-ACP reductase MabA and enoyl-ACP reductase InhA are part of the FAS-II
system, and GFP fusions of these enzymes are located at the polar regions of
growing cells (Fig. 1.2) (Carel et al. 2014). In contrast, β-ketoacyl-ACP synthases
KasA/B are more distributed throughout the cell body perhaps because the
condensing enzymes must acquire C16-18 acyl-CoA released from the cytoplasmic
FAS-I system. C24-26 acyl-CoA is modified to 2-carboxyacylCoA, an important
precursor for MA biosynthesis, by an acylCoA carboxylase complex composed of
AccA3, AccD5 and AccD4 (Gande et al. 2007). The Acc enzyme complex is found at
the polar ends of the cell, physically interacting with DivIVA (Fig. 1.2) (Meniche et al.
2014; Xu et al. 2014) (see below), further indicating that MA production takes place
in the polar regions of mycobacterial cells.
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1.3 Cytoskeletal protein as positional cues for subcellular protein localization
How membrane proteins localize within the mycobacterial cell remains an
open question, but cytoskeletal proteins likely play important roles. For example, in
dividing cells, tubulin-like FtsZ assembles in a ring-like structure near the midcell
and serves as a platform to recruit other proteins required for cell division (Hong,
Deng and Xie 2013). While many rod-shaped bacteria use the actin-like MreB to
organize PG synthesis and to create and maintain their shape (Gitai, Dye and
Shapiro 2004; Shiomi, Sakai and Niki 2008; Billings et al. 2014), mycobacteria have
no known ortholog of MreB. The lack of MreB demands a different mechanism for
spatial positioning of cell envelope biosynthesis in mycobacteria. In this section, we
describe known cytoskeletal proteins in mycobacteria as well as a group of coiled
coil proteins that are likely involved in the early stage of determining the subcellular
membrane protein localization.

1.3.1 FtsZ, divisome and division plane determination
FtsZ localizes near the center of mycobacterial cell where the future division
plane is generated (Fig. 1.2) (Dziadek et al. 2003; Datta et al. 2006; Plocinski et al.
2012; Eskandarian et al. 2017; Rego, Audette and Rubin 2017). Depletion or
overexpression of FtsZ in mycobacteria results in filamentous cells that fail to form
septa (Dziadek et al. 2003). In E. coli, GTP hydrolysis by FtsZ was pointed to
generate force for the Z-ring to constrict membranes (Mukherjee and Lutkenhaus
1998; Lu, Reedy and Erickson 2000; Osawa, Anderson and Erickson 2008; Allard
and Cytrynbaum 2009), but recent findings suggest that the GTPase activity is
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instead necessary for regulated assembly of FtsZ, and the septum closure and
membrane constriction is driven by envelope synthesis (Coltharp et al. 2016;
Monteiro et al. 2018). In mycobacteria, the GTPase activity of FtsZ is necessary for
its function (Rajagopalan et al. 2005a), but the Z-ring is more stable, with
significantly slower GTPase activity than its E. coli counterpart (White et al. 2000;
Chen et al. 2007). The physiological significance of these differences remains
unknown.
Homologs of known divisome proteins, which modulate the dynamic
activities of FtsZ at different levels, have been identified in mycobacteria. Among
them, SepF is an FtsZ-interacting protein that is crucial to form and stabilize the Zring (Fig. 1.2) (Gupta et al. 2015), consistent with its role in other Gram-positive
bacteria as a critical membrane-bound protein that recruits FtsZ (Duman et al.
2013). FipA, another FtsZ-interacting protein, forms a ternary FtsZ-FipA-FtsQ
complex (Fig. 1.2) (Sureka et al. 2010). It is needed only under oxidative stress to
stabilize the Z-ring and FtsZ-FtsQ interaction, and the FipA-FtsZ interaction depends
on phosphorylation of FipA by PknA. Nonetheless, the FtsZ-FtsQ interaction can also
be mediated by CrgA (Fig. 1.2) (Plocinski et al. 2011), possibly explaining why FipA
is dispensable for the FtsZ-FtsQ association under normal growth. In other bacteria,
FtsQ is a component of FtsBLQ subcomplex important for septal ring activity (Liu et
al. 2015; Tsang and Bernhardt 2015). FtsB and FtsL were recently identified in
mycobacteria, and their septal localization is dependent on FtsQ (Wu et al. 2018),
indicating that mycobacterial FtsBLQ might play a similar role in septal ring
formation. One more potential partner of FtsZ that is needed for proper septation is
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WhmD (Gomez and Bishai 2000; Raghunand and Bishai 2006). WhmD-GFP showed
cytoplasmic localization, which led to the initial conclusion that it is not associated
with the divisome, but recent in vitro studies suggested that it interacts and
stabilizes FtsZ (Fig. 1.2) (Bhattacharya, Kumar and Panda 2017), warranting further
investigations to determine its precise role. In addition to these FtsZ-interacting
positive regulators, there are negative regulators that interfere with cell division
(Dziedzic et al. 2010; England, Crew and Slayden 2011). Taken together, the
mycobacterial divisome is being revealed as a complex protein machinery with
intricate regulatory systems to precisely control cell envelope biosynthesis and
remodeling.
The Min and nucleoid occlusion systems ensure precise septum formation at
midcell in E. coli and B. subtilis by using either polar or DNA-bound proteins that
inhibit FtsZ polymerization (Dajkovic et al. 2008; Monahan et al. 2014).
Mycobacteria, however, lack the Min system, and the presence of a nucleoid
occlusion system is still being investigated. One study showed that the Z-ring forms
randomly, independently of DNA positioning, which resulted in cells septating at
subpolar regions and/or containing no DNA (Singh et al. 2013). Other groups have
found that division occurs at or near midcell, resulting in daughter cells with
variable but comparable lengths (Takade et al. 1983; Rajagopalan et al. 2005b; Joyce
et al. 2012; Vijay, Anand and Ajitkumar 2012; Santi et al. 2013; Gola et al. 2015;
Eskandarian et al. 2017; Rego, Audette and Rubin 2017; Senzani et al. 2017). In
particular, a recent study in M. smegmatis visualized the in vivo dynamics of the
chromosomal terminus of replication in addition to the replisome and the
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chromosomal origin of replication (oriC) during cell cycle (Logsdon et al. 2017). The
authors provided rigorous data sets, demonstrating that the positioning of the
chromosomal terminus as well as the replisome prior to division is off-centered,
being slightly closer to the new pole. This offcentered positioning of two replicated
chromosomes predicts the site of septum formation, implying the potential presence
of a nucleoid occlusion system. In addition, another recent report provided evidence
that the Z-ring positioning is not random (Eskandarian et al. 2017). Using correlated
optical and atomicforce microscopy, the authors revealed the undulating surface of
mycobacterial cells and further demonstrated that the Z-ring forms on the
waveform troughs of their surface. Remarkably, these waveform troughs are
present as morphological features in the mother/grandmother cells long before Zring formation. The authors proposed that these morphological landmarks serve as
licensed locations for the Z-ring formation. Using a mutant defective in DNA
partitioning (lacking the ParAB system, see section ‘ParA and segregation of DNA’),
they further showed that the presence of the nucleoid can negatively influence the
Z-ring formation, supporting the idea that a nucleoid occlusion system does exist in
mycobacteria.

1.3.2 ParA and segregation of DNA
ParA and MinD comprise a class of cytoskeletal proteins that are uniquely
found in bacteria (Gitai 2007; Cho 2015). While MinD is absent in actinobacteria, the
ParAB system is widely distributed. Chromosomal DNA segregation is an active,
vital process that needs to be executed reliably each time cells divide. Recent studies
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revealed that M. smegmatis mutants lacking either parA or parB, while being viable,
show chromosomal segregation defects resulting in more frequent appearance of
anucleate cells (Jakimowicz et al. 2007; Ginda et al. 2013). OriC-proximal parS
sequences is the signature recognized by mycobacterial ParB (Jakimowicz et al.
2007), and phosphorylation of ParB regulates its DNA binding and polar localization
within the cell (Baronian et al. 2015). ParA also facilitates the interaction of ParB
and parS in vitro (Jakimowicz et al. 2007). In vivo, ParA physically interacts with
DivIVA (see below), transiently localizes to the new pole and drives the separation
of the duplicated ParB-parS complex to the opposite poles, indicating its critical role
in spatial segregation of chromosomal DNA (Donovan et al. 2010; Ginda et al. 2013,
2017).
Donovan and colleagues also revealed ParA-like proteins involved in division
site determination, Rv1708 and Rv3213c in M. tuberculosis. While overproduced
GFP fusions of M. tuberculosis ParA and Rv1708 showed similar polar enrichment,
GFP-tagged Rv3213c showed more homogeneous membrane fluorescence
(Maloney, Madiraju and Rajagopalan 2009). These authors further demonstrated
that overproduction of these M. tuberculosis proteins in M. smegmatis made the cells
filamentous with multiple nucleoids. These observations suggest that these ParA
homologs may also play roles in spatially controlling cell-cycle progression.

1.3.3 DivIVA and asymmetric cell envelope elongation
DivIVA (also known as Wag31 or Ag84 in mycobacteria) is a widely
conserved coiled coil protein in bacteria. In actinobacteria, it was first shown to be
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essential for apical growth and enriched at the cell poles in Brevibacterium
lactofermentum and Streptomyces coelicolor (Flärdh 2003; Ramos et al. 2003).
Accumulating evidence suggests that DivIVA is key for orchestrating polar growth in
mycobacteria (Fig. 1.2). First, DivIVA localizes asymmetrically at the cell tips and is
enriched at the older, faster growing pole (Nguyen et al. 2007; Kang et al. 2008; Jani
et al. 2010; Meniche et al. 2014; Botella et al. 2017). Second, the phosphorylation of
the protein positively regulates its localization and correlates with optimal growth
and more intense polar staining by fluorescent vancomycin (Kang et al. 2008; Jani et
al. 2010). Finally, silencing or depletion of DivIVA results in bulged and spherical
cells, suggesting that it is important for maintaining the rod morphology (Kang et al.
2008; Meniche et al. 2014). Given that the protein physically interacts with enzymes
required for MA precursor synthesis (Carel et al. 2014; Meniche et al. 2014; Xu et al.
2014), it appears that at least one function of DivIVA is to organize the envelope
biogenesis to promote polar growth and rod shape. Recruitment of DivIVA, in turn,
has been hypothesized to be dependent on a curvature-sensing mechanism and on
the availability of envelope precursors (Meniche et al. 2014). In the future, one
strategy for untangling the complex relationships between cell shape, cytoskeletallike proteins and envelope synthesis may be to ‘start from scratch’ and examine
these interactions during de novo pole formation (Billings et al. 2014; Meniche et al.
2014; Ranjit, Jorgenson and Young 2017).
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1.3.4 FilP lament and polarisome
FilP is a coiled coil protein found in S. coelicolor. It is distantly homologous to
DivIVA, and has been shown to form a lament both in vitro and in vivo. FilP interacts
with DivIVA, the main component of apical protein complex known as polarisome in
Streptomyces (Fuchino et al. 2013). The filP deletion mutant shows morphological
defects and reduced tolerance to mechanical stress (Bagchi et al. 2008), suggesting
its roles in structural integrity of the cellular architecture. A FilP homolog is found in
many species of Mycobacterium, although it is notably missing in M. smegmatis. The
M. bovis homolog, Mb1709, has been shown to form a lament in vitro (Bagchi et al.
2008). While M. tuberculosis ortholog Rv1682 is predicted to be non-essential based
on genome-wide transposon mutagenesis studies (Grif n et al. 2011), it is intriguing
if the protein binds to DivIVA and plays roles in cell morphology and mechanical
strength as observed in S. coelicolor.

1.3.5 SepIVA, a DivIVA-like protein at the divisome
A novel coiled-coil protein termed SepIVA (MSMEG_2416), reported recently
in M. smegmatis (Wu et al. 2018), is a distant homolog of DivIVA. The gene is
predicted to be essential in M. tuberculosis (Griffin et al. 2011), and found widely in
mycobacteria, including the degenerate genome of M. leprae. It was identified as a
protein associated with the divisome (Fig. 1.2), and its depletion results in cells
elongating without dividing, leading to long branched filamentous cells. SepIVA
becomes enriched at the septum transiently during cell division, and septal
enrichment of FtsZ precedes that of SepIVA. When cells are not dividing, SepIVA
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appears to associate with the intracellular membrane domain (IMD), a spatially
distinct domain of the PM (see below), suggesting a dynamic property to change its
subcellular localization during cell cycle.

1.3.6 PspA and membrane stress response
PspA/RsmP are another important group of coiled coil proteins. RsmP, a
corynebacteria-specific protein, which forms a lament in vitro and in vivo, is
upregulated upon DivIVA depletion, and is required for polar growth of C.
glutamicum (Fiuza et al. 2010). PspA, in contrast, is widely conserved in bacteria
and mediates stress response to membrane damage (Joly et al. 2010; Flores-Kim
and Darwin 2016; Manganelli and Gennaro 2017). Mycobacterial pspA is part of a
regulon controlled by mprAB-sigE and clgR (Manganelli et al. 2001; He et al. 2006;
Estorninho et al. 2010). The MprAB two-component system and Sigma factor E (σE)
sense cell envelope stress, positively regulate each other, and activate the
transcription factor ClgR that induces the expression of the clgR-pspA-rv2743crv2742c operon (Manganelli et al. 2001; He et al. 2006; Barik et al. 2010; Tiwari et
al. 2010; Bretl et al. 2014). The observation that PspA is part of this regulon
suggests a link between envelope stress signaling and envelope maintenance.
Indeed, PspA interacts with mycobacterial membranes (Rumschlag et al. 1990;
Mawuenyega et al. 2005; Datta et al. 2015), and the membrane localization is
mediated through a complex formation with two membrane proteins, Rv2743c and
Rv2742c (White et al. 2011; Datta et al. 2015). This protein complex is proposed to
have an envelope-stabilizing function similar to that observed in Gram-negative
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bacteria (Provvedi et al. 2009; Datta et al. 2015). Nonetheless, another study
reported that pspA deletion mutant shows unaltered resistance to envelope stress,
and suggested that PspA is involved in lipid droplet homeostasis (Armstrong et al.
2016), possibly implying a divergent role of PspA in mycobacteria.

1.4 Membrane heterogeneity and its link to differential protein localization
There is accumulating evidence that bacterial PM is not homogeneous (Barák
and Muchová 2013; Farnoud et al. 2015; Matsumoto et al.2015; Huangand London
2016; López and Koch 2017). However, the contribution of membrane
heterogeneity to the spatial coordination of the cellular processes in mycobacteria
remains largely unknown. Here, we will discuss the current understanding.

1.4.1 Microscopic evidence supporting the presence of PM heterogeneity
M. tuberculosis was one of the first microbes examined by EM. Numerous
early studies suggested that mycobacteria, like many other bacteria, have
intracellular membrane-bound structures that were variably called
intracytoplasmic membranous configurations, mitochondrial equivalents or
mesosomes. The earliest studies reporting mycobacterial mesosomes were
published in 1957 (Shinohara, Fukushi and Suzuki 1957; Zapf 1957), and
investigation on these structures continued for the next few decades in
mycobacteria as well as in other bacteria. However, the physiological roles of these
structures were never proven and cryo-EM technologies eventually revealed these
structures as artifacts of chemical fixation (Nanninga et al. 1984; Ryter 1988). Since
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then, there has been no convincing EM evidence for the presence of lateral
heterogeneity of the mycobacterial PM.
In prokaryotic cell biology, the use of fluorescent probes had been limited
because of cell size and resolution constraints of light microscopy. Christensen and
collaborators were the first to describe the lateral heterogeneity of mycobacterial
membrane using fluorescent lipid probes (Christensen et al. 1999). Probes with
different hydrophobic and amphiphilic properties revealed different labeling
patterns of mycobacterial cell envelope and membranes (Christensen et al. 1999),
suggesting differences either in lateral composition of the cellular membranes or in
the physical state of the lipids.
FM4-64 is a hydrophobic red fluorescent dye that has been used to visualize
PM domains in E. coli (Fishov and Woldringh 1999). It has been used to visualize
mycobacterial cell membranes as well, but unlike E. coli, the dye shows
homogeneous annular fluorescence in mycobacteria with more intense
accumulation in the septal region, without indication of lateral membrane
heterogeneity (Maloney, Madiraju and Rajagopalan 2009; Plocinski et al. 2011;
Singh et al. 2013; Fay and Glickman 2014; Kieser et al. 2015; Sharma et al. 2016;
Wu, Gengenbacher and Dick 2016). This result may suggest that mycobacteria do
not form PM domains. However, FM4-64 has been used a membrane-impermeant
dye to examine the membrane dynamics during Bacillus sporulation (Pogliano et al.
1999; Sharp and Pogliano 1999), and there has been no verification of the exact
subcellular locations FM4-64 is staining in mycobacteria. Therefore, it is possible
that the dye is trapped in the OM without reaching the PM.
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Nonyl acridine orange (NAO) is a fluorescent dye thought to be specific to CL.
A recent study suggested that NAO actually binds not only to CL but also other lipids
such as phosphatidylglycerol (Oliver et al. 2014), but a specific biophysical
mechanism of polar phosphatidylglycerol accumulation in E. coli remains unclear
(Matsumoto et al. 2015). NAO has been used to visualize membrane domains in both
M. smegmatis and M. tuberculosis, and the staining was found at the poles and septa
(Maloney et al. 2011). This finding is consistent with the idea proposed in model
bacteria that NAO visualizes CLs that are enriched at areas of negative curvature
such as septa and poles (Mileykovskaya and Dowhan 2000; Kawai et al. 2004).
Because CL is not a major component of the OM (Bansal-Mutalik and Nikaido 2014),
these observations imply that the PM of mycobacteria is laterally heterogeneous.
While sterols are rarely found in bacteria, cholesterol glycolipids exist as
lipid rafts in the OM of Borrelia burgdorferi (LaRocca et al. 2010). In addition,
Bacillus and Staphylococcus are known to form lipid rafts, which are enriched in
squalenes, a class of molecules structurally similar to cholesterols (López and Kolter
2010; García-Fernández et al. 2017). So far, there is no evidence suggesting the
presence of such a liquid-ordered ‘rigid’ membrane microdomain in mycobacteria. A
recent study indicated that various fluorescent cholesterol analogs and their
catabolites stain the PM of M. smegmatis and M. tuberculosis homogeneously
(Faletrov et al. 2017), suggesting that there are no membrane domains to which
such cholesterol analogs can preferentially accumulate. Both M. smegmatis and M.
tuberculosis catabolize cholesterols, and these cholesterol analogs can be oxidized
from 3β-hydroxysterols to 3-ketosteroids. This reaction is thought to be mediated
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by 3β-hydroxysteroid dehydrogenase or cholesterol oxidase. These enzymes are
cytoplasmic FAD/NAD-dependent oxidoreductases (Yang et al. 2007), providing
convincing evidence that the fluorescent cholesterol analogs do reach the
cytoplasmic side of the PM. Indeed, during the time course of BODIPY-cholesterol
labeling in M. smegmatis, homogeneous annular fluorescent patterns transition to
intracellular lipid body labeling in 48 h, further supporting the transient PM labeling
of the cholesterol dye (Faletrov et al. 2017).

1.4.2 PM heterogeneity revealed by centrifugation
Studying the mycobacterial cell using subcellular fractionation techniques
dates back to 1960s (Yamaguchi 1960). The main motivation was to characterize
the functional differences between mesosomes and conventional PM. Later, the
focus of the pursuit shifted to the purification of the OM from the underlying cell
wall and the PM. Despite continuous efforts from many laboratories, the complete
purification of the OM remains challenging. The proteomic analysis of the OM
preparation reported in the most recent study still showed significant enrichment of
PM proteins (Chiaradia et al. 2017), suggesting the tight association of the PM and
cell wall. As detailed below, we have used density gradient fractionation not to
separate the OM from the PM, but to separate a membrane domain from the
conventional PM.
To reveal whether enzymes involved in cell wall biosynthesis are
compartmentalized in the PM, we applied sucrose density gradient fractionation to
crude cell lysates of growing mycobacteria. Initially, two distinct fractions enriched
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in PM phospholipids, termed PMf and PM-CW, were isolated (Morita et al. 2005).
PMf denotes a fraction of the plasma membrane that is free of cell wall components.
This nomenclature was based on the chemical analysis of fractions using thin layer
chromatography and mass spectrometry, showing that the PMf fraction is devoid of
cell wall components such as GPLs and AG. In contrast, the PM-CW is a fraction
containing both PM and cell wall components. More recently, proteomics and
lipidomics demonstrated that the PMf is compositionally distinct from the PM-CW,
and fluorescence microscopy further showed that the fluorescent protein-tagged
PMf-associated proteins (GlfT2 and Ppm1, see below) form discrete regions within
the cell with particular enrichment at the growing cell poles (Hayashi et al. 2016). In
contrast, a fluorescent protein-tagged PM-CW-associated protein (PimE, see below)
showed annular fluorescence, suggesting that the PM-CW is the conventional PM.
Based on these observations, we proposed that the PMf is a membrane domain in
mycobacteria (Hayashi et al. 2016), and renamed the PMf as the IMD (Hayashi et al.
2018).
Proteomic and lipidomic analyses suggest that the IMD is an organizing
center for the biosynthesis of specific metabolites (Hayashi et al. 2016). A notable
feature of the IMD is that it is enriched in particular steps of PM lipid biosynthesis.
For example, AcPIM6 is synthesized from PI by sequential additions of mannose
residues. As shown in Fig. 1.3A, PimB’ and PimE are two mannosyltransferases
involved in transferring the second and fifth mannoses, while PatA is an
acyltransferase involved in transferring a fatty acid to one of the mannose residues
upon the synthesis of PIM2. GDP-mannose-dependent PimB’ is a cytoplasmically
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Figure 1.3. IMD-associated metabolic reactions.
(A) Proposed PIM biosynthesis pathway. The AcPIM2 biosynthesis takes place in the
IMD, whereas AcPIM6 is formed in the PM-CW. There is no experimental evidence
24

for the exact PIM intermediate that flips across the membrane. (B) PA and PE
biosynthesis. PA is synthesized in the IMD, while PE biosynthesis spans both the
IMD and PM-CW. (C) Proposed galactan biosynthesis pathway. The galactan
intermediate is synthesized in the IMD and translocated to the periplasm for further
modification. Neither the flippase for the galactan precursor nor the exact structure
of the flippase substrate is known. (D) PG precursor biosynthesis. Lipid II is formed
in the IMD prior to continuing to the periplasmic PG biosynthesis. The putative
flippase MurJ and penicillin-binding proteins (PBPA/PBPB) are found in the PM-CW
proteome, but additional verification is needed. (E) PPM biosynthesis. Ppm1 acts on
PP forming the mannose donor PPM in the IMD. OM, outer membrane; AG,
arabinogalactan; PG, peptidoglycan; IMD, intracellular membrane domain; PM-CW,
plasma membrane with cell wall; PI, phosphatidylinositol; PIMs,
phosphatidylinositol mannosides; PA, phosphatidic acid; PS, phosphatidylserine; PE,
phosphatidylethanolamine; LM, lipomannan; LAM, lipoarabinomannan.
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oriented enzyme, while PimE is dependent on polyprenolphosphate-mannose,
suggesting that its active site is on the periplasmic side. The AcPIM6 biosynthesis
can be examined in vitro using a radioactive sugar nucleotide, GDP-[3H]mannose.
When each density gradient fraction was incubated with GDP[3H]mannose, the IMD
fractions were found enriched in the initial biosynthetic steps up to AcPIM2,
whereas the PM-CW fractions were enriched in the later steps to form AcPIM6 (Fig.
1.3A) (Morita et al. 2005). Furthermore, the IMD localization of endogenous PimB’
and the PM-CW localization of an epitope-tagged PimE were confirmed by western
blotting (Morita et al. 2006; Sena et al. 2010; Hayashi et al. 2016). A proteomic
analysis additionally revealed that the IMD is enriched in PimB’ as well as PatA.

1.4.3 IMD: a multifunctional membrane domain
There are many additional biosynthetic reactions that appear to be enriched
in the IMD. In 2014, a seminal paper by Meniche et al. reported the concept of the
subpolar space, which is spatially separate from the polar DivIVA-anchored Acc
enzymes and enriched for cell envelope biosynthetic enzymes such as MurG, GlfT2
and Pks13 (Meniche et al. 2014). As detailed below, MurG and GlfT2 are also found
in the IMD proteome, suggesting that the physical nature of the subpolar space is at
least partially fulfilled by the IMD. We also highlight other IMD-associated
metabolism, for which more than one piece of experimental evidence is available to
support the IMD localization.
Phosphatidic acid (PA) is a key biosynthetic intermediate of phospholipid
biosynthesis. It is produced by sequential transfer of fatty acids from acyl-CoA to
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glycerol 3-phosphate. The two acyltransferases likely involved in the PA
biosynthesis are glycerol-3-phosphate O-acyltransferase (GPAT;
MSMEG_4703/Rv1551) and 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT;
MSMEG_4248/Rv2182c) (Larrouy-Maumus et al. 2013; Law and Daniel 2017).
These two enzymes were enriched in the IMD proteome (Hayashi et al. 2016).
Furthermore, lipidomic analysis showed that PA was enriched in the IMD (Hayashi
et al. 2016), consistent with the enrichment of the PA biosynthetic enzymes (Fig.
1.3B). These data together support the notion that PA biosynthesis takes place in the
IMD.
Similar to AcPIM6 biosynthesis, the final two steps of PE biosynthesis have
been examined by a cell-free system using [3H]serine and [3H]phosphatidylserine
(PS). PS synthase reaction was enriched in the PM-CW, while the PS decarboxylase
(Psd) reaction was found in the IMD (Morita et al. 2005) (Fig. 1.3B). Proteomic
analysis supported the radiolabeling experiment: Psd was found enriched in the
IMD (Hayashi et al. 2016).
Galactan, a component of AG, is synthesized as a polyprenol-linked
precursor. The linker between galactan and PG is composed of l-Rhap-d-GlcNAc-PO4
where phosphate is attached to the glycan backbone of PG (Bhamidi et al. 2008).
This linker is synthesized as a part of the polyprenol-linked galactan precursor, and
sequentially mediated by d-GlcNAc-1-phosphate transferase (Rv1302), rhamnosyl
transferase WbbL (Rv3265c) and galactosyltransferase GlfT1 (Rv3782) (Mikusova
et al. 1996; Weston et al. 1997; Mills et al. 2004). The polymerization of galactan
chain beyond the addition of the first two galactose residues by GlfT1 is mediated by
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a processive galactosyltransferase GlfT2. The IMD proteome is enriched in WbbL,
GlfT1 and GlfT2 (Fig. 1.3C). An M. smegmatis strain expressing HA-mCherry-GlfT2 at
the endogenous locus further demonstrated the enrichment of the fusion protein in
the density gradient fractions corresponding to the IMD (Hayashi et al. 2016).
Fluorescent microscopy also revealed a patchy distribution of GlfT2 at the sidewall
plus polar enrichment (Fig. 1.2) (Meniche et al. 2014; Hayashi et al. 2016).
Lipid II is the polyprenol-linked precursor of PG biosynthesis. MurG is the
key enzyme that transfers GlcNAc to lipid I resulting in lipid II, and is enriched in the
IMD proteome (Fig. 1.3D) (Hayashi et al. 2016). In addition, MurG shows IMD-like
fluorescence pattern (Meniche et al. 2014), supporting its IMD association.
Furthermore, as described above, substantial evidence suggests that PG
biosynthesis is concentrated at the growing cell poles. Therefore, polar enrichment
of the IMD-associated MurG may be important for the spatially controlled
production of lipid II. It would be important to determine the subcellular
localization of other proteins involved PG biosynthesis.
Polyprenol phosphate mannose (PPM) is a polyprenol-linked mannose donor
utilized by mannosyltransferases that act on the periplasmic side of the PM. It is
synthesized by a heterodimer of Ppm1 and Ppm2. Ppm2 is a multitransmembrane
protein that anchors the catalytic subunit Ppm1 to the membrane (Baulard et al.
2003). Ppm1 was found enriched in the IMD proteome (Fig. 1.3E) (Hayashi et al.
2016). Furthermore, Ppm1-mNeonGreencMyc expressed from the endogenous locus
was enriched in the IMD fraction in a density gradient fractionation. Fluorescence

28

microscopy also revealed the colocalization of Ppm1 and GlfT2 (Hayashi et al. 2016),
supporting that Ppm1 is an IMD-associated protein (Fig. 1.2).

1.4.4 Remarkable features of the IMD
A remarkable feature of the IMD is that its associated proteins identified by
proteomic analysis are dominated by proteins with no predicted transmembrane
domains (Hayashi et al. 2016). With a few exceptions, most transmembrane
proteins are excluded from the IMD. This is in contrast to many transmembrane
proteins identified in the PM-CW, suggesting that the lack of these proteins is not
due to the technical limitation of mass spectroscopic fingerprinting. For some IMD
proteins, peripheral membrane association is supported by experimental evidence.
For example, crystal structure of GlfT2 demonstrated hydrophobic and positively
charged patches on the surface of the protein, which are proposed to interact with
membrane phospholipids (Wheatley et al. 2012). Two enzymes involved in the PIM
biosynthesis, a mannosyltransferase PimB’ and an acyltransferase PatA, were also
suggested to have positively charged and hydrophobic residues for peripheral
association with anionic PM lipids (Guerin et al. 2009; Albesa-Jové et al. 2016;
Sancho-Vaello et al. 2017).
Another notable feature is that the IMD is dynamic and spatially relocated
under stress conditions (Hayashi et al. 2018). Because the IMD is enriched near the
poles when the cell envelope actively elongates, we were prompted to examine the
IMD localization when cells are no longer growing. Stationary phase, starvation in
phosphate-buffered saline supplemented with 0.05% Tween-80 and antibiotic

29

treatment were tested as stress models. In all cases, the IMD delocalized from the
pole and redistributed to the sidewall. The IMD could still be biochemically purified
by density gradient fractionation, indicating that the IMD is maintained as a
membrane domain even under these stress conditions. Furthermore, polar IMD
enrichment can be restored when the starved cells were replenished with nutrientrich medium. These data collectively demonstrated the dynamism of the IMD as a
membrane domain. However, the molecular mechanisms of how the IMD responds
to the environmental conditions and relocates within the cell remain completely
unknown.

1.5 Future visions
Mechanistic understanding of the (a)symmetry of mycobacterial elongation
is an important challenge for the future. The controversy over this topic may be in
part because of challenges in marking division events and subsequent outgrowth
(Aldridge et al. 2012; Joyce et al. 2012; Santi et al. 2013; Singh et al. 2013;
Wakamoto et al. 2013; Kieser and Rubin 2014; Siegrist et al. 2015; Botella et al.
2017). One complicating factor may have been the use of fluorescent DivIVA fusions
in several studies to mark the cell division cycle (Santi et al. 2013; Carel et al. 2014).
Expression of these constructs from a strong promoter leads to more even
distribution of the protein (Meniche et al. 2014) and of metabolically labeled PG
(Botella et al. 2017) at either pole. As discussed above, the discovery of the divisome
protein LamA is beginning to unveil the molecular mechanism of growth asymmetry
(Rego, Audette and Rubin 2017). Together, these data raise the possibility that the
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degree of mycobacterial growth asymmetry may depend on environmental
conditions, which in turn could influence the expression levels of LamA, DivIVA or
other, yet-identified deterministic, factors.
Fluorescent fusions have been a powerful tool, but have the potential to alter
the function and/or localization of the tagged proteins in unintended ways
(Landgraf et al. 2012; Swulius and Jensen 2012; Meniche et al. 2014; Botella et al.
2017). Historically, the function of the fluorescent protein fusions was often not
experimentally verified. Moving forward, it will be important to perform functional
assays on mutant strains, and, when possible, opt for monomeric fluorescent tags
that are less prone to clustering artifacts (Landgraf et al. 2012). In many cases,
particularly for envelope biogenesis, small molecule probes will offer a
complementary means for imaging enzyme function (Foss, Eun and Weibel 2011;
Kocaoglu and Carlson 2013; Siegrist et al. 2015).
How lateral heterogeneity of the PM contributes to the positioning of
divisome and formation of the apical protein complex (or mycobacterial
polarisome) remains to be determined. Does the enrichment of CL at the septum
drive DivIVA localization? Is the polar localization of so many proteins solely
dependent on DivIVA? Is the subpolar IMD enrichment dependent on DivIVA? How
do so many proteins localize to the IMD? How does the IMD contribute to
mycobacterial cell physiology? In Bacillus, the presence of detergent-resistant lipid
raft as well as membrane region of increased fluidity (RIF) have been proposed
(López and Kolter 2010; Müller et al. 2016). Lipid rafts are liquid ordered structures
that have low fluidity, while RIF is a conceptually opposite highly fluid region within
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the same PM. Whether the IMD is similar to lipid rafts or RIFs is an important
biophysical question. Interestingly, daptomycin, which disrupt the RIF in Bacillus,
causes the formation of ectopic poles in mycobacteria (Meniche et al. 2014). The
profound effect of daptomycin on mycobacteria might imply the presence of similar
RIF-like region in the PM of mycobacteria.
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CHAPTER 2
DEMETHYLMENAQUINONE METHYL TRANSFERASE IS A MEMBRANE DOMAINASSOCIATED PROTEIN ESSENTIAL FOR MENAQUINONE HOMEOSTASIS IN
MYCOBACTERIUM SMEGMATIS
(Previously published in whole in Frontiers in Microbiology in December 2018)

2.1 Introduction
Mycobacterium smegmatis has a complex membrane organization. In
addition to the inner plasma membrane, long branched fatty acids known as mycolic
acids are covalently anchored to the peptidoglycan-arabinogalactan cell wall core,
and serve as a major component of the outer membrane. In addition to these
topologically distinct membrane layers, the plasma membrane has a spatially
distinct membrane domain known as the Intracellular Membrane Domain (IMD)
(Hayashi et al., 2016; 2018). Experimentally, the IMD can be separated and purified
from the conventional plasma membrane by sucrose density gradient fractionation
of mycobacterial crude cell lysate (Morita et al., 2005). In this gradient fractionation,
the IMD appears as vesicles of phospholipids without significant enrichment of cell
wall components. In contrast, the conventional plasma membrane fraction contains
both membrane phospholipids and cell wall components, suggesting that the
conventional plasma membrane is tightly associated with the cell wall (designated
as PM-CW). A more recent study revealed that the IMD is particularly enriched in
the polar regions of the live actively growing cell, and associated with more than
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300 proteins, among which are enzymes involved in cell envelope biosynthesis
(Hayashi et al., 2016). Mycobacteria extend their cell envelope primarily from the
polar region of the rod-shaped cell, and unlike other model bacteria such as
Escherichia coli or Bacillus subtilis, the cylindrical part of the cell does not actively
elongate (Aldridge et al., 2012; Thanky et al., 2007). Therefore, the polar IMD
enrichment implies the strategic placement of membrane-bound enzymes that are
involved in producing cell envelope biosynthetic precursors (Puffal et al., 2018).
Nevertheless, there are many IMD-associated enzymes that are not involved in the
cell envelope biosynthesis, suggesting more general functions of the IMD as a
spatially distinct area of mycobacterial membrane, including the possible regulation
of cytoplasmic metabolites, which is largely unexplored.
The biosynthetic enzymes for menaquinones (2-methyl-3-polyprenyl-1,4naphthoquinones) are potential examples of such IMD-associated enzymes that are
not directly involved in the cell envelope biosynthesis. Menaquinones are major
lipoquinone electron carriers of mycobacterial respiratory chain. A major final
product of the biosynthetic pathway is referred as MK-9 (II-H2), in which the
number 9 indicates a nonaprenyl lipid chain and II-H2 indicates that the second
double bond is saturated (Collins et al., 1977). Its biosynthesis can be divided into
the initial cytoplasmic reactions followed by the final membrane-associated steps
(Meganathan, 2001). The membrane-associated reactions are mediated by three
enzymes. First, the product of the cytoplasmic reactions, 1,4-dihydroxy-2naphthoate, is attached to a polyprenol lipid by a membrane-bound
polyprenyltransferase known as MenA (Dhiman et al., 2009) (Fig. 2.1). Second, the
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resulting demethylmenaquinone is methylated on the aromatic ring by MenG (syn.
MenH/UbiE), forming menaquinone (Dhiman et al., 2009). Finally, the double bond
in the β-isoprene unit of the polyprenyl chain is reduced by the reductase MenJ to
form the mature product, such as MK-9 (II-H2) (Upadhyay et al., 2015; 2018). Our
comparative proteomic analysis of the IMD and the PM-CW suggested that MenG
and MenJ are enriched in the IMD, while MenA was not detected in either the IMD or
the PM-CW (Hayashi et al., 2016).
Menaquinone biosynthesis is a critical process in mycobacteria. A previous
study revealed Ro 48-8071 as an inhibitor of MenA, and demonstrated that this and
other MenA inhibitors arrest the growth of both Mycobacterium tuberculosis and M.
smegmatis, and reduce the cellular oxygen consumption (Dhiman et al., 2009).
Another group showed that chemical inhibition of MenG is detrimental to the
growth of M. tuberculosis, leading to the reduced oxygen consumption and ATP
synthesis (Sukheja et al., 2017). In contrast, menJ is a dispensable gene in laboratory
growth conditions: its deletion in M. smegmatis and M. tuberculosis produces viable
mutants that show no significant changes in the growth rates (Upadhyay et al.,
2015). Detailed analysis of this mutant revealed that the accumulation
menaquinone-9 (MK-9) instead of MK-9 (II-H2) resulted in reduced electron
transport efficiency. However, the mutant produced an increased amount of MK-9 to
compensate partially for the loss of the mature species, indicating significant
flexibility in meeting with the cellular needs of lipoquinones for respiration.
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Figure 2.1. Last three steps of menaquinone biosynthesis in mycobacteria.
MenA adds a polyprenol such as nonaprenol to 1,4-dihydroxy-2-naphthoic acid
forming DMK-9. MenG methylates the polar ring resulting in MK-9. MenJ reduces
one C=C bond of the second prenyl group to form the mature MK-9 (II-H2).
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Combining evidence for the important roles of these enzymes with the new
proteomic analysis suggesting that MenG and MenJ might be IMD-associated, we
examined if the membrane steps of menaquinone biosynthesis are
compartmentalized within the plasma membrane in M. smegmatis. In the present
study, we directly demonstrated that MenG and MenJ are associated with the IMD
while MenA is associated with the PM-CW. We further demonstrated that menG is an
essential gene in M. smegmatis. Interestingly, partial depletion of MenG was
detrimental to the M. smegmatis cells even though the cellular level of MK-9 and MK9 (II-H2) remained high, implying a critical role of MenG in regulating menaquinone
homeostasis in mycobacterial plasma membrane.

2.2 Material and Methods
2.2.1 Cell cultures
Mycobacterium smegmatis mc2155 was grown as before (Hayashi et al.,
2016) at 30°C in Middlebrook 7H9 broth supplemented with 11 mM glucose, 14.5
mM NaCl, and 0.05% Tween-80, or at 37°C on Middlebrook 7H10 agar
supplemented with 11 mM glucose and 14.5 mM NaCl. When required, the medium
was supplemented with 100 µg/ml hygromycin B (Wako), 50 µg/ml streptomycin
sulfate (Fisher Scientific), 20 µg/ml kanamycin sulfate (MP Biochemicals), or 5%
sucrose.

2.2.2 Construction of plasmids
Plasmids used in this study are summarized in Table S1.
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pMUM040 – To create expression vector for MenA which is C-terminally
tagged with a hemagglutinin (HA) epitope, the gene was amplified by PCR (Table S2)
using primers carrying appropriate restriction enzyme sites. The product was
digested with BspEI and ligated to the vector backbone of pMUM038, which was
linearized by BspEI/SspI double-digestion. The pMUM038 vector is identical to
pMUM011 (Hayashi et al., 2016), a derivative of pVV16, but its sole NdeI site was
removed by linearizing the plasmid using NdeI, blunting using the T4 polymerase,
and circularizing using a DNA ligase.
pMUM042 – To create expression vector for MenG, which is C-terminally
tagged with an HA epitope, the PCR product (Table S2) was inserted by blunt-end
ligation to the vector backbone of pMUM012 (Hayashi et al., 2016), linearized by
EcoRV and ScaI. This intermediate plasmid, pMUM039, was then double-digested
with NdeI and ScaI, and the fragment carrying menG gene was ligated into the
linearized vector backbone of pMUM040 digested with the same enzymes.
pMUM055 – To knockout the endogenous menG gene, we amplified upstream
and downstream regions of menG using the primers shown in Table S2 and digested
with Van91I and DraIII, respectively. The two fragments were then ligated into
Van91I-digested pCOM1 as previously described (Hayashi et al., 2016). The
resulting plasmid, pMUM055, was used for allelic exchange of menG in M. smegmatis
via a two-step recombination process as previously described (Hayashi et al., 2016;
Rahlwes et al., 2017). The deletion of the menG gene was confirmed by PCR using
primers A312 and A313 (Table S2).
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pMUM098 – To create a MenG-HA expression vector with a kanamycin
resistance selection marker, menG-HA gene fragment was isolated from pMUM042
(see above) by XmnI/EcoRI double digestion, and was inserted to XmnI/EcoRI
double-digested pMUM087. pMUM087 is an NdeI-free version of pMV361 (Stover et
al., 1991) (gift from Dr. William R. Jacobs Jr., Albert Einstein College of Medicine),
created by digesting pMV361 with NdeI, and blunt-ending and re-ligating the
linearized fragment.
pMUM103 – To create an expression vector for MenJ-HA, the gene was
amplified by PCR (Table S2), and the PCR product was inserted directionally to
pMUM098, from which the preexisting insert was removed by NdeI/ScaI double
digestion.
pMUM058 – To create an expression vector for MenG tagged with
mTurquoise, the mTurquoise gene was amplified by PCR (Table S2) from pYAB281
containing mTurquoise (Hayashi et al., 2016). The PCR product was then digested
with ScaI and inserted to pMUM042, which was linearized by the same enzyme,
creating an expression vector for C-terminally mTurquoise-HA epitope-tagged
fusion protein.
pMUM119 – To create a dual-control tet-off expression vector for MenG, in
which the protein is fused with HA epitope and DAS degradation tag at the Cterminus, we first created an intermediate construct pMUM106 by Gibson assembly
of ClaI/NdeI double-digested pDE43-MCS (Blumenthal et al., 2010), the PCR
amplified promoter region of pEN12A-P766-8G (A442/A443, Table S2) (Kim et al.,
2013) (gift from Dr. Christopher Sassetti, University of Massachusetts Medical
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School), and the PCR-amplified menG gene from pMUM090 (A444/A445, Table S2),
resulting in a MenG expression vector driven by the weak P766-8G promoter. We
then inserted a fragment for the expression of TetR38, which was PCR-amplified
from pEN41A-T38S38 (A487/A488, Table S2) (Kim et al., 2013) and digested with
EcoRV and BspTI, into pMUM106 digested with EcoRV and BspTI, resulting in
pMUM110. To attach the HA and DAS tags, the menG-HA fragment was amplified by
PCR (A185/A506, Table S2) from pMUM098. The PCR fragment and pMUM110 were
digested with SacI and VspI and ligated, creating pMUM119. The SspB expression
vector (pGMCT-3q-taq25) and non-replicative integrase expression vector (pGAOX15-int-tw) (gift from Dr. Christopher Sassetti, University of Massachusetts
Medical School) were co-electroporated to allow stable integration of pGMCT-3qtaq25.
Plasmid constructs (Table S1) were electroporated into M. smegmatis for
integration and homologous recombination as previously described (Hayashi et al.,
2016).

2.2.3 Density gradient fractionation and protein analysis
Log phase cells (OD600 = 0.5-1.0) were pelleted, lysed by nitrogen cavitation,
and subjected to sucrose density fractionation as previously described (Hayashi et
al., 2016). Briefly, 1.2 ml of the lysate was loaded on top of a 20-50 % sucrose
gradient prepared in a 14 x 95 mm tube (Seton Scientific). The gradient was spun at
35,000 rpm (218,000 x g) for 6 h at 4oC in a SW-40 rotor (Beckman-Coulter).
Thirteen 1-ml fractions were then collected and used for further biochemical
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analysis. Protein concentration was determined by the bicinchoninic acid (BCA)
assay (Pierce). Sucrose density was determined by a refractometer (ATAGO). For
SDS-PAGE and western blotting, an equal volume of each fraction was loaded as
described before (Hayashi et al., 2016; 2018).

2.2.4 Fluorescence microscopy
Fluorescence microscopic live imaging was done as previously described
(Hayashi et al., 2016).

2.2.5 Plasmid swap
Expression vectors, pMUM098 (menG-HA, Kanr) and pMUM087 (empty
vector, Kanr), were electroporated into M. smegmatis DmenG L5::menG-HA Strr strain
to swap the inserted plasmid at the L5 integration site. The swapping was verified
by culturing the transformed colonies on Middlebrook 7H10 plates containing
kanamycin or streptomycin.

2.2.6 menG conditional knockdown
M. smegmatis DmenG L5::menG-HA Kanr was transformed with the plasmid
pMUM119 (tetOff menG-HA-DAS Strr) to swap at the L5 integration site to create

DmenG L5::tetOff menG-HA-DAS Strr. This new strain was then transformed with
pGMCT-3q-taq25/pGA-OX15-int-tw (tetOn sspB Kanr), an integrative plasmid that
recombines at an attB site for the mycobacteriophage Tweety (Pham et al., 2007),
resulting in the menG dual-switch knockdown strain, DmenG L5::tetOff menG-HA-DAS
Strr Tweety::tetOn sspB Kanr.
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A starter culture of the dual-switch menG knockdown strain, grown in
Middlebrook 7H9 medium containing streptomycin and kanamycin, was inoculated
into fresh Middlebrook 7H9 medium with or without 100 ng/ml
anhydrotetracycline (ATC) and subsequently sub-cultured by 100-fold dilution
every 24 h. One ml of each culture was taken for OD600 reading to monitor the
growth, and colony forming unit (cfu) was determined at the 72-h time point. As
controls, we used M. smegmatis strains carrying Tweety::tetOn sspB Kanr alone. For
menaquinone-4 (MK-4) supplementation, we prepared 80 mM MK-4 stock solution
in dimethyl sulfoxide and slowly added to a culture to achieve a final concentration
of 400 µM, following a previously published protocol (Dhiman et al., 2009). To
analyze the protein depletion kinetics, western blot images were recorded and
quantified using ImageQuant LAS4000mini (GE Healthcare).

2.2.7 Mass spectrometric analysis of lipids
A previously reported comparative lipidomics dataset (reproduced in Fig.
S2A) (Hayashi et al., 2016) was further analyzed for annotations of several
menaquinone species based on mass, which were subjected to validation by
collision-induced dissociation mass spectrometry. For targeted analysis of
menaquinone, we grew the cells in the presence and absence of ATC for 72 h, subculturing at every 24 h and harvested cells at 72 h. Cells were lysed by nitrogen
cavitation and the lipids were extracted from the whole cell lysate. For lipid
extraction, 500 µl of cell lysates were supplemented with 10 nmol of MK-4
(Millipore-Sigma) as an internal standard. Six ml ice-cold 0.2 M perchloric acid in
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methanol was added along with 6 ml petroleum ether (preheated to 40-60oC) as
described previously (Bekker et al., 2007). The mixture was vortexed and spun, and
the top organic layer was transferred to a new tube. The lower layer was extracted
again with 6 ml of petroleum ether and the organic extracts were combined. The
combined organic extract was washed once with 6 ml of water, and the final top
organic layer was transferred to a new tube, dried and resuspended in 100 µl
chloroform/methanol (1:1). To evaluate the extraction efficiency, we subjected 10 µl
to thin layer chromatography and orcinol/H2SO4 staining for the detection of a
phosphatidylinositol dimannoside species known as AcPIM2 (Morita et al., 2004).
The AcPIM2 bands were imaged and quantified using Fiji (Schindelin et al., 2012),
and used to normalize the lipid concentration between samples.
The purified lipids were subjected to high-performance liquid
chromatography (HPLC)-tandem mass spectrometry (Orbitrap Fusion with higher
energy collisional dissociation (HCD) coupled with UltiMate 3000 HPLC system,
Thermo Scientific), using PC-HILIC column (Shiseido) with acetonitrile/water (95:5)
with 10 mM ammonium acetate (pH 8.0) as the mobile phase. The ESI was operated
in a positive polarity mode, with spray voltage of 2.8 kV and flow rate of 0.3 ml/min.
The full scan range was 100 to 1,200 m/z and the data was recorded using Xcalibur
3.0.63 software package (Thermo Scientific). For HCD, a quadrupole isolation mode
was used with collision energy of 40±5% and data detected by Orbitrap (Thermo
Scientific). The targeted m/z were defined as 771.6075 for demethylmenaquinone-9
(DMK-9), 785.6231 for MK-9, 787.6388 for MK-9 (II-H2), and 445.3101 for MK-4.
The detection efficiency of MK-9 relative to MK-4 was determined using 20 pmol of
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commercially available MK-9 (Santa Cruz biotechnology) and MK-4 (MilliporeSigma).

2.2.8 Oxygen consumption
The effect of MenG depletion on oxygen consumption was evaluated by
methylene blue decolorization. One OD unit of each culture from the 72-h time point
was harvested, resuspended in 2 ml of Middlebrook 7H9, and supplemented with
0.001% methylene blue (Ricca). In sealed cuvettes, oxygen consumption was
monitored by absorbance at 665 nm.

2.2.9 Measurement of cellular ATP levels
The dual-switch menG knockdown strain was incubated in the presence and
absence of ATC for 72 h, sub-culturing at every 24 h, as described above.
Intracellular ATP was determined by BacTiter Glo microbial cell viability assay
(Promega), following manufacturer’s instruction.

2.3 Results
2.3.1 The maturation of MK-9 takes place in the IMD
The three final steps of MK-9 biosynthesis are catalyzed by the enzymes
MenA, MenG and MenJ (Fig. 2.1). MenA is a protein with multiple predicted
membrane spanning domains. MenG and MenJ have no predicted transmembrane
domains, but we previously showed by comparative proteomics that peptide
fragments corresponding to known MenG and MenJ sequences were recovered at
higher level in the IMD than in the conventional plasma membrane (PM-CW)
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(Hayashi et al., 2016). Thus, MenG and MenJ are potentially IMD-associated proteins
peripherally bound to the membrane surface. However, our proteomic analysis did
not examine the cytoplasmic fraction, and therefore cannot exclude the possibility
that these proteins reside also in the cytoplasm.
To determine the subcellular localization of these three enzymes based on direct
detection of intact proteins in all three compartments, we expressed MenA-HA
(expected molecular weight, 29 kDa), MenG-HA (25 kDa) and MenJ-HA (44 kDa)
individually at the site-specific integration site of mycobacteriophage L5 in M.
smegmatis, and confirmed that all three proteins were expressed at the expected
molecular weight (Fig. S1). We then performed sucrose density gradient
fractionation of each strain, and determined the subcellular localization of these
enzymes within the gradient. PimB’ and MptA are the protein markers for the IMD
and PM-CW, respectively, and MenA-HA was enriched in the fractions
corresponding to the PM-CW together with MptA (Fig. 2.2A). In contrast, MenG and
MenJ were enriched in the IMD (Fig. 2.2B-C). The low density fractions (Fr. 1-2), that
are high in total protein content, are known to be enriched in cytoplasmic proteins
(Hayashi et al., 2016; Morita et al., 2005). Neither MenG nor MenJ was found in the
cytoplasmic fraction, indicating that these two proteins are stably associated with
the IMD.
To determine the subcellular localization of MenG in live bacteria, we next
introduced an MenG-mTurquoise-HA expression vector, and expressed the
fluorescent fusion protein in a previously established M. smegmatis strain
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Figure 2.2. Subcellular localization of menaquinone biosynthesis.
(A-C) Sucrose density gradient fractionation of cell lysates prepared from strains
expressing (A) MenA-HA, (B) MenG-HA and (C) MenJ-HA. Total protein
concentration profile indicates that the low density region where the protein
concentrations are high (fractions 1-2) corresponds to the cytoplasm fraction.
Sucrose density profile confirms proper gradient formation. Protein markers for the
IMD and the PM-CW were PimB’ (41 kDa) and MptA (54 kDa), respectively. Minor
localization of MenJ-HA to the PM-CW region was not reproducible. All experiments
were done more than twice and representative data are shown.
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expressing HA-mCherry-GlfT2 from the endogenous glfT2 locus. GlfT2 is a
galactosyltransferase involved in the arabinogalactan precursor synthesis, and is an
IMD-associated protein (Hayashi et al., 2016). We first confirmed by sucrose density
gradient that MenG-mTurquoise-HA co-fractionates with HA-mCherry-GlfT2 and
PimB’ (Fig. 2.3A), but not with the PM-CW marker, MptA. The expected molecular
weights of HA-mCherry-GlfT2 and MenG-mTurquoise-HA are 100 and 50 kDa,
respectively, allowing separate detection of these two HA-tagged proteins in a single
western blot. This result also revealed the relatively lower expression level of
MenG-mTurquoise-HA in comparison to HA-mCherry-GlfT2, even though the
expression of MenG is driven by a strong promoter. Consistent with the apparently
lower MenG expression in cellular extracts, we also observed a much weaker level of
fluorescence from mTurquoise by fluorescence microscopy live imaging compared
to the HA-mCherry-GlfT2 observed in the red channel (Fig. 2.3B). In addition to the
weak fluorescence, M. smegmatis has diffuse autofluorescence in the blue channel
that gives a higher background than other channels (Patiño et al., 2008)(Fig. 2.3C).
These technical limitations made the image analysis difficult, but we were able to
observe the polar enrichment of MenG-mTurquoise-HA, which correlated with the
polar enrichment of HA-mCherry-GlfT2 (Fig. 3.3B).
To determine if any menaquinone species are enriched in the IMD, we
analyzed a comparative HPLC time-of-flight (TOF) mass spectrometry-derived
lipidomic dataset comprised of 11,079 separately detected molecular events
(Hayashi et al., 2016). This method was previously validated to extract hydrophobic
molecules, including menaquinones, and normal phase chromatography reduces
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Figure 2.3. Co-localization of MenG with the IMD associated protein GlfT2.
(A) Sucrose density fractionation of strain expressing HA-mCherry-GlfT2 (100 kDa)
and MenG-mTurquoise-HA (50 kDa). The epitope-tagged proteins were detected by
anti-HA antibody. PimB’ (41 kDa) and MptA (54 kDa), respectively, indicate the IMD
and PM-CW fractions. (B) Fluorescence microscopy showing localization of both
MenG-mTurquoise-HA and HA-mCherry-GlfT2 at the pole of growing M. smegmatis
cells. (C) Autofluorescence of wild-type M. smegmatis on blue channel observed
under the identical image acquisition setting as in panel B. Scale bar = 5 µm. All
experiments were done more than twice and representative data are shown.
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cross-suppression by more polar species, allowing semiquantitative detection of
lipid compounds (Lahiri et al., 2016; Layre et al., 2011). The IMD preparations were
previously validated based on IMD-specific proteins and revealed IMD-associated
phospholipids among compounds enriched in the IMD. The majority of these
compounds were unnamed, but are discoverable based on matching their m/z
values with the MycoMap dataset (Layre et al., 2011). This approach allowed the
identification of signals matching the m/z value of DMK-9 and MK-9 in their reduced
and non-reduced forms. While DMK-9 was equally present in both sites, the MK-9
species appeared to be enriched in the IMD (Fig. S2A). Although the enrichment was
slightly below the cutoff of statistical significance (Fig. S2A), each data point in the
volcano plot was the average of four independent experiments involving culture
growth, density gradient fractionation, lipid extraction and mass spectrometric
analysis. When we examined four biological replicates individually, we found MK-9
species consistently enriched in the IMD in four independent experiments (Fig.
S2B), suggesting that this slight IMD enrichment is reproducible. The identity of
both MK-9 (II-H2) and MK-9 were confirmed by collision-induced dissociation mass
spectrometry (Fig. S2C), showing that they are in the ketone form with a reduced
double bond in the nonaprenyl lipid moiety of MK-9 (II-H2). Taken together, these
data suggest that 1) MenA produces DMK-9 in the PM-CW; 2) DMK-9 relocates from
the PM-CW to the IMD; 3) MenG methylates DMK-9 to generate MK-9 in the IMD;
and 4) MenJ reduces the prenyl lipid of MK-9 to form the mature molecule, MK-9 (IIH2), in the IMD (Fig. 3.4). For MK-9 (II-H2) to function as an electron carrier, it may
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then have to relocate back to the PM-CW because the respiratory chain enzymes are
found in the PM-CW (Hayashi et al., 2016).

2.3.2 The menG gene is essential in M. smegmatis
The intricate spatial segregation of biosynthetic enzymes suggests that
menaquinone biosynthesis may be a highly regulated process. The association of
this pathway also implies an indirect role of the IMD in the central energy
metabolism. Nevertheless, little is known why the MenG- and MenJ-dependent
modifications on DMK-9 are physiologically important. MenJ is dispensable for
growth of both M. tuberculosis and M. smegmatis in standard laboratory growth
conditions (Upadhyay et al., 2015). In contrast, menG is predicted to be essential in
M. tuberculosis (Griffin et al., 2011), but no direct or indirect information about its
essentiality is available for M. smegmatis.
To begin delineating the function of MenG, we first attempted to knock out menG by
a markerless deletion using a plasmid that carries sacB gene as a negative selection
marker and hygromycin resistance gene as a positive selection marker (Hayashi et
al., 2016) (Fig. S3A). We confirmed the establishment of a single-crossover mutant
that is sensitive to sucrose (due to sacB gene) and resistant to hygromycin. We then
grew the single-crossover mutant in nonselective medium to allow the second
crossover event, and isolated 17 colonies that are resistant to sucrose and sensitive
to hygromycin. When we analyzed these double-crossover candidates, they were all
found to be wild-type revertants and no candidate had the menG deletion (data not
shown). These initial observations suggested that menG is an essential gene.
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To test this further, we created a merodiploid strain of the single-crossover mutant,
in which a menG expression vector with a streptomycin resistance marker
(pMUM042) was inserted at the L5 integration site (Fig. S3A). We successfully
isolated double-crossover mutants from the merodiploid single-crossover strain, as
confirmed by PCR of the endogenous menG gene locus (Fig. S3B). Using the doublecrossover mutant, we attempted to swap the menG expression vector, pMUM042,
carrying streptomycin resistance marker with another L5-integrative menG
expression vector, pMUM098, carrying kanamycin resistance marker or with an
empty vector, pMUM087, carrying kanamycin resistance marker as a control. When
pMUM098 was used, 240 colonies were obtained (Fig. S4). We patched 78 colonies
on Middlebrook 7H10 medium containing either streptomycin or kanamycin, and
found that all 78 colonies were sensitive to streptomycin and resistant to
kanamycin, suggesting that pMUM042 was swapped with pMUM098. In contrast,
when the empty vector pMUM087 was used, only 3 colonies were obtained and they
were all resistant to both kanamycin and streptomycin, suggesting that the cells
could not lose pMUM042 carrying menG gene. Using a newly established kanamycinresistant strain carrying pMUM098, we attempted to swap back using streptomycinresistant pMUM042. Again, we were able to isolate 20 colonies using pMUM042, but
no legitimate swapping occurred using the empty vector, pMUM038 (Fig. S4). Taken
together, these data strongly support that menG is an essential gene.
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Figure 2.4. Proposed spatial compartmentalization of MK-9 biosynthetic
pathway.
DMK-9 is formed in the PM-CW by the prenyltransferase MenA. DMK-9 traffics to
the IMD and modified by MenG and MenJ, forming MK-9 and MK-9 (II-H2),
respectively. The mature molecule can then be transferred to the PM-CW to serve as
an electron carrier. The red line in the polyprenol moiety of MK-9 (II-H2) indicates
the saturation of the second isoprene unit mediated by MenJ. SAM, Sadenosylmethionine.
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2.3.3 MenG depletion leads to growth arrest without significant depletion of
menaquinone
To examine the mechanistic basis of MenG essentiality in M. smegmatis, we
constructed a cell line with a dual-control switch in which ATC suppresses the
expression of menG and degrades MenG protein simultaneously (Fig. 3.5A) (Kim et
al., 2013). In this DmenG L5::tetOff menG-HA-DAS Strr Tweety::tetOn sspB Kanr strain,
an inducer ATC turns off the transcription of menG-HA-DAS gene. At the same time,
the transcription of sspB gene is turned on, and the SspB adaptor protein recognizes
and targets the DAS-tagged protein for ClpXP-dependent degradation. Upon
addition of ATC, the cells started to show deficiency in growth after two consecutive
series of 24-h sub-culturing. The OD600 reading for the treated cells became
significantly lower after 3 rounds of sub-culturing (Fig. 3.5B). The higher OD600
values achieved after the first 24 h incubation in comparison to subsequent cultures
is likely due to the higher growth density of the seed culture to initiate this
experiment. The cfu for untreated and ATC-treated cultures were 1.8 x 107 and 5.2 x
106 cfu/ml, respectively, comparable to the OD measurements, suggesting MenG
depletion is bacteriostatic rather than bactericidal. We examined the protein level of
MenG over the time course of one biological replicate, and found that total protein
fell to ~76% of the level found in untreated cells by 48 h (Fig. 3.5C). This moderate
suppression of MenG continued even at the 72 h time point, where the MenG protein
was reduced further to the ~35% of the level found in untreated cells (Fig. 3.5C).
The relatively mild MenG depletion made us wonder if the lack of growth is due to
the depletion of menaquinone. In M. tuberculosis, the growth arrest by the MenG
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inhibitor was rescued by the addition of MK-4 as a surrogate menaquinone (Sukheja
et al., 2017). Therefore, we added MK-4 to see if exogenously added menaquinone
can rescue the growth of the mutant in the presence of ATC. As shown in Fig. S5,
MK-4 supplementation was unable to rescue the growth of the ATC-treated cells,
suggesting that the growth defect of the mutant might not be due to the depletion of
menaquinone.
To evaluate the impact of MenG depletion on cellular menaquinone levels, we
took the 72-h time point, and performed HPLC tandem mass spectrometry analysis
on the lipid extracts from crude lysates. We confirmed the identity of MK-9 (m/z
785.6231), MK-9 (II-H2) (787.6388), and DMK-9 (771.6075) by fragmentation (Fig.
S6), and quantified the levels of each species relative to the internal standard MK-4
(m/z 445.3101).
As expected, we saw a significant increase in the DMK-9 levels when cells
were treated with ATC (Fig. 3.6A). Surprisingly, the levels of MK-9 and MK-9 (II-H2)
were not significantly different between the untreated and MenG-depleted strains
(Fig. 3.6B-C). These data support the idea that the partial depletion of MenG leads to
the accumulation of the MenG substrate, DMK-9, immediately impacting cellular
metabolic activities prior to affecting the cellular levels of MK-9 and MK-9 (II-H2).

2.3.4 Impact of MenG depletion on respiration and cellular ATP levels
Because MenG depletion appears to have no immediate effect on the levels of
MK-9 and MK-9 (II-H2), we examined if cellular respiration is affected upon MenG
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depletion. Cells were grown as previously for 72 h with sub-culturing at every 24 h,
and aliquots of cell suspension was tested for O2 consumption using the
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Figure 2.5. MenG knockdown.
(A) Scheme of MenG depletion. When the DmenG L5::tetOff menG-HA-DAS Strr
Tweety::tetOn sspB Kanr strain is exposed to ATC, a tetracycline analog, MenG
expression is shut off and the protein is tagged for degradation by SspB. (B) Growth
curve of DmenG L5::tetOff menG-HA-DAS Strr Tweety::tetOn sspB Kanr exposed to ATC
over 72 h of sub-culturing every 24 h. The averages of biological triplicates are
shown with standard deviations, demonstrating a statistically significant difference
between ATC – and + at 72 h time point (*, p < 0.05 by t-test). (C) MenG depletion
after 48 and 72 h of ATC treatment detected by western blotting of one biological
replicate. Images were captured by the ImageQuant LAS4000mini image
documentation system and bands were quantified using ImageQuant analysis
software (GE Healthcare). ATC, anhydrotetracycline. All experiments were done
more than twice and representative data are shown.
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decolorization of methylene blue. We found that the untreated (ATC-) cells rapidly
depleted the O2 from the media, but the treated (ATC+) cells consumed very little O2
during the same period
(Fig. 3.7A), suggesting that respiration in the ATC+ cells is significantly reduced
even though these cells are viable as indicated above by the cfu.
The severe reduction in the rate of aerobic respiration suggested an impact
on the central metabolism. We next examined the cellular level of ATP when the
cells were treated with ATC during the third sub-culturing from the 48-h time point
to the 72-h time point. We found that the MenG-depleted (ATC+) cells accumulated
~3 times more ATP than the untreated (ATC-) cells (Fig. 3.7B). This was not due to
the SspB expression because a control cell line, which only expresses SspB upon
ATC addition, did not show any changes in cellular ATP levels (Fig. S7). These data
are consistent with the idea that MenG depletion resulted in the reduction of the
cellular metabolism, and the lack of energy consumption resulted in the
accumulation of ATP.
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Figure 2.6. Changes in menaquinone species upon MenG depletion.
Lipid extracts from crude cell lysates were analyzed by HPLC mass spectrometry to
quantify (A) DMK-9, (B) MK-9 and (C) MK-9 (II-H2). In three independent
experiments, lysates were prepared after 72-h growth with or without ATC
(biological triplicates). From each replicate of the biological triplicates, lipids were
extracted and analyzed twice (technical duplicates). MK-4 was added as an internal
standard to control the efficiency of lipid extraction and HPLC mass spectrometry
analysis. Each point in the graphs is the average of the technical duplicate, and the
grey line represents the average of biological triplicates. The unit is pmol of
indicated menaquinone species per µl of cell lysate. *, p < 0.05 by t-test.
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Figure 2.7. Effect of MenG depletion on aerobic respiration and intracellular
ATP level.
(A) Oxygen consumption by M. smegmatis MenG depletion strain after 72-h with and
without treatment with ATC. The decolorization of methylene blue in the media was
used as an indication of the oxygen consumption, taking the A665 of methylene blue
immediately after the addition of ATC (at 0 min) as 100%. (B) ATP accumulation
over a 24-h period during the third sub-culturing from the 48-h to the 72-h time
point with and without ATC. The averages of biological triplicates are shown with
standard deviations. ATC, anhydrotetracycline.
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2.4 Discussion
The IMD is a metabolically active membrane domain that mediates many
distinct biosynthetic pathways. In this study, we demonstrated that the final
maturation steps of the menaquinone biosynthesis take place in the IMD, and MenG,
one of the IMD-associated enzymes, is essential for the growth of M. smegmatis. The
IMD association of MenG is supported by three lines of evidence gathered in vitro
and in live cells. First, proteomic analysis indicated that MenG is more enriched in
the IMD than in the PM-CW (Hayashi et al. 2016). Second, epitope-tagged MenG was
biochemically localized to the IMD by density gradient fractionation. Finally,
fluorescent protein-tagged MenG showed colocalization with a known IMD marker
at polar regions of actively growing cells by fluorescence microscopy. Although we
cannot completely rule out the possibility that the HA epitope and fluorescent tags
interfere with the subcellular localization, the IMD localizations of the fusion
proteins were consistent with the proteomic identification of the endogenous
protein in the IMD as mentioned above. Combined with the IMD localization of
epitope-tagged MenJ, we suggest that menaquinone species, MK-9 and MK-9 (II-H2),
are produced in the IMD. Indeed, the comparative lipidomic analysis suggested that
MK-9 (II-H2) as well as MK-9 are relatively enriched in the IMD, but overall do not
show the high levels of segregation as seen for the proteins that act on them. These
observations suggest cellular regulation of the enzymes with substrates diffusing
between both sites.
Do menaquinones have a functional role in the IMD or is it merely produced
there? We propose that menaquinones function as an electron carrier for some IMD-
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associated enzymes. For example, we have previously shown that the
dihydroorotate dehydrogenase PyrD, an enzyme involved in pyrimidine
biosynthesis, is an IMD-associated protein (Hayashi et al., 2016). Mycobacterial
PyrD is a member of the class 2 dihydroorotate dehydrogenases (Björnberg et al.,
1997; Munier-Lehmann et al., 2013), which utilize quinones instead of NADH as an
electron acceptor. Therefore, de novo synthesized menaquinones are locally
available to support the IMD-resident PyrD reaction.
Nevertheless, a major fraction of menaquinones must also be available for
cytochromes in the respiratory chain. Our comparative proteomic analysis
suggested that the respiratory chain cytochromes as well as H+-ATPases are
enriched in the conventional plasma membrane (Hayashi et al., 2016). For example,
the subunits of cytochrome c reductase (QcrCAB; MSMEG_4261-4263) and aa3
cytochrome c oxidase (CtaC; MSMEG_4268), as well as the subunits of H+-ATPases
(e.g. alfa, beta, H, F and A; MSMEG_4938, MSMEG_4936, MSMEG_4939,
MSMEG_4940, MSMEG_4942, respectively) are enriched in the PM-CW proteome.
Furthermore, the major NADH oxidase reactions take place in the PM-CW (Morita et
al., 2005). Together, menaquinones produced in the IMD may be relocated to the
PM-CW to support cellular respiration. Whether menaquinones diffuse through
different membrane areas or require a transport mechanism remains an important
question to be addressed in the future.
Several independent lines of experimental evidence clearly indicated that
MenG is an essential protein in M. smegmatis. In the dual-switch knockdown system,
the depletion of MenG protein was only partial even after three consecutive 24-h

75

sub-cultures. We do not know why this mutant shows this unusual protein depletion
kinetics, but speculate that the protein degradation is not efficient and MenG might
have a prolonged half-life. Nevertheless, this mild MenG depletion led to the growth
arrest. Why is this mild MenG depletion detrimental to M. smegmatis? Indeed, MK-9
is still abundantly present after three 24-h sub-cultures with ATC induction. The
MenG substrate, DMK-9, however, showed a significantly increase in the treated
population. We speculate that MenG might play a key regulatory role in the IMD, and
the disruption of the balance between MK-9 and DMK-9 by its partial depletion
could induce metabolic shutdown and the cessation of growth.
In M. tuberculosis, a recent study demonstrated that MenG is an effective drug
target, and its inhibition led to the reduced oxygen consumption and ATP
production. Our data in M. smegmatis is consistent with the previous findings in M.
tuberculosis in that MenG is an essential protein, but also illuminate some important
differences. First, we could not rescue the MenG depletion by the addition of MK-4,
while exogenously supplemented MK-4 was apparently incorporated into the
plasma membrane to function as a surrogate electron carrier in M. tuberculosis in
the presence of MenG inhibitor (Sukheja et al., 2017). Second, MenG depletion in M.
smegmatis did not lead to the reduction in ATP production. These differences could
possibly be attributed to the differing chemical versus genetic methods of
perturbation used in the two studies. Importantly, DMK, which accumulates upon
MenG perturbation, is a fully functional electron carrier in Escherichia coli (Sharma
et al., 2012; Unden and Bongaerts, 1997; van Beilen and Hellingwerf, 2016),
implying that the physiological importance of the MenG-mediated methylation of
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the DMK aromatic ring in mycobacteria is not merely a matter of the mid-point
electron potential of quinones as electron carriers.
Why does ATP accumulate during MenG depletion? In many other bacteria,
when proton gradient formation is compromised, ATP synthase can be reversed to
hydrolyze ATP and used to reestablish the proton gradient (Ballmoos et al., 2009).
In mycobacteria, on the other hand, such reverse action of ATP synthase is blocked
and cannot be used to energize the membrane (Haagsma et al., 2010). Therefore,
even when the cells are exposed to hypoxic conditions and cannot create a sufficient
level of proton motive force, the accumulating ATP in the cell might not be utilized
for energizing the membrane.
MenG expression is upregulated in response to the depletion of Sadenosylmethionine, indicating one example of transcriptional regulations of menG
in response to the changing metabolic state of the cell (Berney et al., 2015). We
speculate that MenG depletion might be mimicking an adaptive response to an
environmental change, leading the cells to stop aerobic respiration and
consumption of ATP. In addition, we cannot rule out the possibility that the cells
start using an alternative electron acceptor instead of oxygen. Such an adaptive
response is known in E. coli (Edwards et al., 2006; Georgellis et al., 2001; Malpica et
al., 2004), where changes in the environmental oxygen level result in a switch of
lipoquinone species used in the electron transport chain. In this regard, when
oxygen is depleted in mycobacteria, hydrogenases are suggested to drive the
electron transport chain in the absence of exogenous electron acceptors (Berney
and Cook, 2010), allowing continued production of ATP.
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While menaquinones are the main lipoquinone for mycobacteria during
aerobic growth, the biosynthesis of isoprenoid precursors is markedly
downregulated during hypoxia, resulting in a depletion of menaquinones (Honaker
et al., 2010; Matsoso et al., 2005). Under such hypoxic conditions, addition of the
MK-9 analogue MK-4 (vitamin K2) or the saturated form (vitamin K1) is harmful
and reduces the survival of M. tuberculosis (Honaker et al., 2010). A more recent
study demonstrated that hypoxic conditions in a biofilm lead to the biosynthesis of
polyketide quinones, which are alternative electron carriers that are produced by
the type III polyketide synthases (Anand et al., 2015). These previous studies
indicate that lipoquinone biosynthesis is a highly regulated process, controlled by
sensing changing environmental factors. Our study showed that a partial depletion
of MenG leads to the accumulation of DMK-9 without significant changes in the MK9 pool. We speculate that this imbalance of DMK-9 and MK-9, induced by the MenG
depletion, has a global impact on metabolic activity and thus, growth. While further
studies are needed to understand the complex changes in menaquinone metabolism
during MenG depletion, our current study highlights the spatial complexity of
menaquinone biosynthesis, and the essential role of MenG, an IMD-associated
protein, in maintaining the metabolic homeostasis and the active growth of M.
smegmatis.

2.5 Supplemental figures and tables

78

Table S1. Plasmids used in this study.
Plasmid name
pMUM38
pMUM40
pMUM42
pMUM55
pMUM58
pMUM87
pMUM98
pMUM119
pGMCT-3q-taq25
pGA-OX15-int-tw

Description
Empty vector
Expression vector for menA-HA
Expression vector for menG-HA
Knockout construct to replace endogenous menG
Expression vector for menG-mTurquoise-HA
Empty vector
Expression vector for menG-HA
Expression vector for menG-HA-DAS
Expression vector for sspB
Non-replicative vector for integrase expression

Table 2.S1. Plasmids used in this study
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Selection
Str
Str
Str
Hyg/Suc
Str
Kan
Kan
Str
Kan
Amp

Table S2. Oligonucleotides used for PCR amplification.
Plasmid

Gene

pMUM039

menG

pMUM040

menA

pMUM055

pMUM058

Upstream
menG
Downstream
menG
mTurquoise

pMUM103

menJ

N/A

menG KO

pMUM106

P766-8G
promoter
menG

pMUM110

TetR38

pMUM119

menG-HA

Forward Primer
Reversed Primer
A185 atccataTGAGTCGAGCGAGCTTGGAGAAGA
A186 actGGCGGGCTTGGTGG
A166 tcatccccgatccggaggaatcacttccatATGGCCAGTTTCGCGCAGT
A167 actGTGGAACGCCAGCGGGAT
A243 ttttttttcacagagtgGAATTCCGAGAATTCACACG
A244 ttttttttcacaatgtgGCTCGCTCGACTCACGACG
A245 ttttttttccagattttggCACCAAGCCCGCCTAG
A246 ttttttttccaacttttggGTCTCAAACCGATCCGCGAAA
A241 ccagtactaatattGTTAGTAAAAGAGAAGAAC
A242 CTCGTCGGCTTCGAGTGC
A459 ttttttttcatatgATGAACACCCGAGCGGATGTG
A460 actGCTGAACGGCACCCGCTGAT
A312 CGGGCTTGCCGATTTTCG
A313 CGGGTTACCAACCTCTGGTTA
A442 gctagttaactacgtcgacatcgatttcccttaagattagatatcccgacaattgGCTGCT
ACCAGGCCTAGATCTG
A443 ccccatggtaccagaaagcttGGTGGTGCATGCGGTTGT
A444 aagctttctggtaccatggGGACAGAAAGGAGGAAGGAAT
A445 aagtcgtcgccaccaatccccatatgctcgagtcgcgaattaatGACTGATAGTG
ACCTGTTCGTTG
A487 ggggaaacttaagAGCTGGCTAGCGAGTCATGAGGT
A488 cccccccgatatcAATATTGGATCACGCCGCGAG
A185 atccataTGAGTCGAGCGAGCTTGGAGAAGA
A506 tttttcccATTAATTCAGCTGGCGTCCGCGTAGTTCTCGGAG
TAGTTCTCGTCGTTGGCGGCCGCGTAGTCCGGGACGTC

Table 2.S2. Oligonucleotides used for PCR amplification
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Figure S1

MenA MenG MenJ
kDa
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37
25
20

Figure S1. Expression of epitope tagged MenA-HA (30 kDa), MenG-HA (25 kDa) and MenJHA (44 kDa), detected
with2.S1.
anti-HA
antibody.
Figure
Expression
of epitope tagged proteins

M. smegmatis expressing MenA-HA (30 kDa), MenG-HA (25 kDa) and MenJ- HA (44
kDa), detected with anti-HA antibody.
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Figure S2
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demethylmenaquinone. (B) Intensity plot of MK-9 species between the IMD and PMCW. DMK-9 and DMK-9 (II-H2) are equally present in both fractions and MK-9 and
MK-9 (II-H2) species are slightly enriched in the IMD. (C) Collision-induced
dissociation mass spectroscopy for MK-9 and MK-9 (II-H2).
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Figure S3
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Figure 2.S3. Endogenous menG deletion is only possible with extra menG copy.
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Figure S4
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Figure S4. Plasmid swap in a menG background is only possible with MenG expression
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( menG::empty KanR) resulted in no colonies. Electroporation of pMUM042
( menG::menG-HA StrR) into menG::menG-HA KanR resulted in plasmid swap, while
the empty vector pMUM038 (menG::empty StrR) failed to generate colonies.
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Figure S5

Figure 2.S5. MK-4 does not rescue MenG depletion.
Growth curve of menG::tetoff menG- DAS::teton sspB exposed to ATC with and
without
supplementation
over 72 Growth
h of sub-culturing
24 h. off menGFigure S5. MK-4
doesMK-4
not rescue
MenG depletion.
curve of every
menG::tet

DAS::teton sspB exposed to ATC with and without MK-4 supplementation over 72 h of
sub-culturing every 24 h.
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4

Figure S6

8

Figure S6. MK species detection confirmation. Representative fragmentation of parental
MKand
species
detection
confirmation.
ions DMK-9 m/z 771.6075, Figure
MK-9 m/z2.S6.
785.6231,
MK-9 (II-H
2) m/z 787.6388. Both
Representative
fragmentation
ofpresent
parental
ions DMK-9
m/z 771.6075,
MK-9 m/z
signature
fragments 173.4295
and 211.2811 are
after DMK-9
fragmentation,
and
187.0753
and 225.0910
MK-9
and2MK-9
785.6231,
andafter
MK-9
(II-H
) m/z(II-H
787.6388.
Both signature fragments 173.4295 and
2) fragmentation.

211.2811 are present after DMK-9 fragmentation, and 187.0753 and 225.0910 after
MK-9 and MK-9 (II-H2) fragmentation.
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Figure S7

Figure 2.S7. ATP accumulation in WT::teton sspB.
ATP accumulation measured over a 24-hour period with and without ATC inducing
Figure S7. ATP accumulation
in of
WT::tet
sspB.
ATP accumulation measured over a 24-hour
only expression
SspB. on
ATC,
anhydrotetracycline.

period with and without ATC inducing only expression of SspB. ATC, anhydrotetracycline.
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CHAPTER 3

CONSERVED METABOLIC FUNCTIONS OF THE INTRACELLULAR MEMBRANE
DOMAIN IN MYCOBACTERIUM TUBERCULOSIS

3.1 Introduction
Unlike many other bacteria, mycobacteria and related bacilli in the
Acitnobacteria class grow by depositing de novo synthesized cell envelope materials
at the pole rather than the sidewall of the cell (Kieser and Rubin, 2014, Aldridge et
al, 2012, Rego et al, 2017). The cell envelope of mycobacteria is formed by a complex
structure composed of plasma membrane, peptidoglycan, arabinogalactan layer and
mycomembrane (Minnikin, 1982). The precise coordination of this cell envelope
synthesis is necessary for cell elongation, therefore, it is conceivable that proteins
involved in this process are spatially organized in the cell. Indeed, there are many
proteins that are known to show spatial enrichment in mycobacteria (Puffal et al,
2018a). In particular, DivIVA is associated with the pole of the cell and its physical
interaction with early cell elongation machinery is suggested to determine the
cellular growth site (Meniche et al 2014; Melzer et al 2018). The recruitment of
other mycolic acid, arabinogalactan, and peptidoglycan biosynthetic enzymes
determine a subpolar localization where new cell wall components are made to be
incorporated to the nascent pole (Meniche et al 2014; García-Heredia et al, 2018).
Polar enrichment is observed not only for proteins but also for membrane lipids.
Plasma membrane heterogenicity was first shown by Christensen and collaborators
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(1999) using fluorescent lipid probes. More recently, an enrichment of cardiolipin to
the pole of growing cells has been documented (Maloney et al, 2011).
Previously, we reported the presence of a growth-pole associated membrane
domain, the IMD, in the non-pathogenic model organism Mycobacterium smegmatis
(Hayashi et al, 2016; 2018; Morita et al, 2005). This domain was shown to be
different from the conventional plasma membrane associated with cell wall, PM-CW.
Among a variety of functions associated with this membrane domain, lipid
metabolism has been reported to be associated with the IMD, which houses
numerous essential enzymes involved in lipid biosynthetic reactions. For instance,
while one of the major components of the mycobacterial membrane,
phosphatidylinositol mannosides (PIMs), were found in both IMD and PM-CW, its
biosynthesis was revealed to be distributed between the two (Hayashi et al, 2016).
Another important lipid involved in respiration, menaquinone, was discovered to be
matured in the IMD of M. smegmatis (Puffal et al, 2018b). These data demonstrate
the diversity of reactions happening in this domain with different significance in the
cellular polar growth and central metabolism of the cell.
In this study, we investigated the presence of the IMD in Mycobacterium
tuberculosis, a pathogenic species of mycobacteria. We first sought to establish its
biochemical separation through cytosolic- and PM-CW-associated protein markers
as well as lipid species and the metabolic capacity of the IMD membrane domain in
the synthesis of phosphatidylinositol mannosides (PIMs). Next, we establish an IMD
proteome by comparing the protein populations of the IMD in M. smegmatis and M.
tuberculosis. Finally, we visualized the localization of the IMD in live growing M.
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tuberculosis. We suggest that the IMD is a growth pole-associated membrane
domain conserved in the genus Mycobacterium.

3.2 Material and Methods
3.2.1 Cell cultures
Mycobacterium tuberculosis mc2-6230 ΔRD1/panCD strain was grown in 7H9
Middlebrook media supplemented with 10 % OADC (170 mM oleic acid, 5%
albumin, 3.6 M dextrose, 473 mM NaCl, 0.004 % catalase), 0.05% Tween 80, and 50
µg/ml panthoteic acid. When required, the medium was supplemented with 100
µg/ml hygromycin B (Wako), 20 µg/ml kanamycin sulfate (MP Biochemicals), or 5%
sucrose.

3.2.2 Density gradient fractionation and protein analysis
Log phase cells (OD600 = 0.5-1.0) were lysed and subjected to sucrose density
fractionation as described previously (Hayashi et al, 2016). The protein
concentration for each fraction was determined by bicinchoninic acid (BCA) assay
(Pierce). Sucrose density of each fraction was determined by a refractometer
(ATAGO). SDS-PAGE and western blotting of the sucrose gradient fractionation were
performed using equal volume of each fraction as described before (Hayashi et al,
2016).

3.2.3 Radiolabeling
To analyze PIMs biosynthesis, a GDP-[3H]Mannose incorporation assay was
performed for each sucrose density fraction as described before (Morita et al, 2005),
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except 1 hour of incubation was allowed for the incorporation. After recovery of
PIMs as described previously, the lipids were resolved on high performance thin
layer chromatography (HPTLC) silica gel in chloroform/methanol/13 M ammonia/1
M ammonium acetate/water (180:140:9:9:23, v/v) and visualized by fluorography
using En3Hance after 3 months exposure.

3.2.4 Lipid analysis
Lipids were extracted from 800 µl of each gradient fraction as described
before (Morita et al, 2005). They were analyzed by HPTLC silica gel and developed
in chloroform/methanol/13 M ammonia/1 M ammonium acetate/water
(180:140:9:9:23, v/v). Cardiolipin (CL), phosphatidylethanolamine (PE) and
phosphatidylinositol (PI) detected by molybdenum blue, and PI mannosides (PIMs)
by orcinol-H2SO4 staining.

3.2.5 Negative staining electron microscopy
Samples of pooled sucrose gradient fractions of IMD and PM-CW were
pelleted at 100,000x g and washed with HES buffer (25mM HEPES pH7.4, 2mM
EGTA, 150mM NaCl). Preparation of samples for EM was done as previously (Morita
et al, 2005).

3.2.6 Proteome preparation and analysis
As described above, pooled IMD and PM-CW fractions were pelleted and
washed in biological triplicates. The protein samples were then separated on a 12%
SDS-PAGE gel for a short distance and the entire protein region of the gel excised
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and subjected to in-gel trypsin digestion after reduction with DTT and alkylation
with IAA. Peptides eluted from the gel were lyophilized and re-suspended in 16-25
µL of 5% acetonitrile (0.1%(v/v) TFA) with 0.1 pmol ADH digest. A 3-3.8 µL
injection was loaded by a Waters NanoAcquity UPLC in 5% acetonitrile (0.1%
formic acid) at 4.0 µL/min for 4.0 min onto a 100 µm I.D. fused-silica pre-column
packed with 2 cm of 5 µm (200Å) Magic C18AQ (Bruker-Michrom). Peptides were
eluted at 300 nL/min from a 75 µm I.D. gravity-pulled analytical column packed
with 25 cm of 3 µm (100Å) Magic C18AQ particles using a linear gradient from 535% of mobile phase B (acetonitrile+ 0.1% formic acid) in mobile phase A (water+
0.1% formic acid) over 90 minutes. Ions were introduced by positive electrospray
ionization via liquid junction at 1.6kV into a Thermo Scientific Q Exactive hybrid
mass spectrometer. Mass spectra were acquired over m/z 300-1750 at 70,000
resolution (m/z200) with an AGC target of 1e6, and data-dependent acquisition
selected the top 10 most abundant precursor ions for tandem mass spectrometry by
HCD fragmentation using an isolation width of 1.6 Da, max fill time of 110 ms, and
AGC target of 1e5. Peptides were fragmented by a normalized collisional energy of
27, and fragment spectra acquired at a resolution of 17,500(m/z200).
Raw data files were peak processed with Proteome Discoverer (version2.1,
Thermo) followed by identification using Mascot Server (version2.5, Matrix Science)
against the TubercuList (release27), all annotations as
per https://mycobrowser.epfl.ch/. Search parameters included Trypsin/P
specificity, up to 2 missed cleavages, a fixed modification of carbamidomethyl
cysteine, and variable modifications of oxidized methionine, pyroglutamic acid for Q,
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and N-terminal acetylation. Assignments were made using a 10 ppm mass tolerance
for the precursor and 0.05 Da mass tolerance for the fragments. All non-filtered
search results were processed by Scaffold (version4.4.4, Proteome Software, Inc.)
utilizing the Trans-Proteomic Pipeline (Institute for Systems Biology) with
threshold values set at 70% for peptides and 95% for proteins (2 peptide
minimum), and quantitative comparisons made using total spectra with all samples
normalized by total ion current for the run. The analysis was done as previously and
proteins with minimum spectral counts of 10 and a minimum of two-fold
enrichment in either the IMD or the PM-CW were considered to be part of the
respective proteome (Hayashi et al, 2016). Functional annotation was performed
using DAVID Bioinformatics Resourses as described previously (Hayashi et al,
2016).
The refined proteome analysis was done using IMD fractions from cells
expressing PyrD-HA and wild-type. Immunoprecipitation using HA-agarose beads
(Pierce), proteome analysis and functional annotation analysis were done as before
(Hayashi et al, 2016).

3.2.7 Construction of plasmids
pMUM036 – To create expression vector for PyrD, which is C-terminally
tagged with an HA epitope, the pyrD gene was amplified with primers A052/A053
and PCR product was digested with SspI and inserted by blunt-end ligation to the
vector backbone of pMUM012 (Hayashi et al, 2016).
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pMUM145 – To create an endogenous epitope tagged PyrD, upstream and
downstream of the pyrD gene were amplified using primers A536/A537 and
A538/53 from genomic M. tuberculosis DNA. The products were digested with
Van91I. The two fragments were then ligated into Van91I-digested pCOM1 as
previously described (Hayashi et al, 2016) to create an intermediate expression
vector for PyrD, pMUM133. tagRFP was amplified and HA tag was added using
primers A557/A558 from pMUM134, a plasmid containing tagRFP (Gift from Sasseti
Lab). The PCR product and the plasmid were then digested with VspI and BspT1 to
create a N-terminally 2xHA-tagRFP epitope-tagged fusion PyrD.
pMUM215 – To create expression vector for Psd, which is C-terminally
tagged with NeonGreen-HA, psd was amplified using primers A60/A631) and
fragment was digested with NdeI and MfeI. pMUM111 was used, which is a derivate
from pMUM098 (Puffal in press) containing mNeongreen in addition to HA epitope
tag. The vector was digested with the same restriction enzymes and insert ligated.
Plasmid constructs were electroporated into Mycobacterium tuberculosis
mc2-6230 ΔRD1/panCD for integration and homologous recombination as previously
described (Hayashi, et al)

3.2.8 Structured Illumination Microscopy (SIM) imaging
Images were acquired by Nikon Eclipse Ti N-SIM E microscope equipped
with a Hamamatsu Orca Flash 4.0 camera (numerical aperture of 1.49) as described
before (Melzer et al, 2018), and reconstructed on NIS Elements.
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3.3 Results
3.3.1 Evidence of the presence of the IMD in wild type M. tuberculosis
Taking the same approach previously established for M. smegmatis, we
prepared a lysate of exponentially growing M. tuberculosis cells, and fractionated by
density gradient sedimentation. We determined the density and the protein
concentration of each fraction by refractive index and bicinchoninic acid (BCA)
protein assay, respectively (Fig. 3.1A). As previously seen in M. smegmatis, the
majority of proteins is enriched in the top two fractions. In this density gradient, we
have previously shown in M. smegmatis that cytoplasmic proteins are retained in the
top fractions and do not sediment significantly. To confirm that the protein
enrichment in the top fractions corresponds to cytoplasmic proteins, we performed
a western blotting against the cytoplasmic enzyme Ino1, an inositol-3-phosphate
synthetase (Bachhawat et al, 1999), and detected this protein predominantly in
fractions 1 and 2 (Fig. 3.1B). To examine the localization of membrane proteins in
denser region of the gradient, we performed a western blotting against the
mannosyltransferase MptC, which is a polytopic membrane protein found in the PMCW in M. smegmatis. We detected M. tuberculosis MptC in the denser region of the
gradient, spanning from fractions 8 to 11 (Fig. 3.1B). These fractions correspond to
the density of 1.127-1.154 g/ml, which is comparable to 1.131-1.159 g/ml found for
M. smegmatis PM-CW (Puffal et al, in press), indicating that MptC is a PM-CW protein
in M. tuberculosis as well.
To examine if there is another membrane fraction corresponding to the IMD
in addition to the PM-CW fraction in M. tuberculosis, we examined the compositional
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profiles of plasma membrane phospholipids. Lipids were extracted from each
fraction and visualized by chemical staining. As shown in Fig. 3.1C, membrane
phospholipids cardiolipin (CL), phosphatidylethanolamine (PE) and PI were
detected by molybdenum blue staining in the PM-CW fractions as well as another
fraction spanning from fraction 3 to 6. This lighter density region was relatively
depleted of PE. Furthermore, orcinol staining for glycolipids revealed that the same
light density fractions were enriched in monoacyl PIM species, but was devoid of
diacyl PIM species. Taken together, these pieces of evidence suggested that there is
an additional membrane containing fraction separated from the PM-CW fraction.
Would this light-density phospholipid-containing fraction correspond to the IMD?
One signature reaction taking place in M. smegmatis IMD is the biosynthesis of
polyprenol-phosphate-mannose. We have previously shown that the PPM
biosynthetic activity is enriched in the IMD and the enzyme Ppm1 was found
exclusively in the IMD in M. smegmatis (Morita et al, 2005; Hayashi et al, 2016). To
determine the localization of this biosynthetic reaction in M. tuberculosis, we
performed a cell-free radiolabeling assay using GDP-[3H]mannose as a mannose
donor. We detected the incorporation of this carbohydrate in fractions 3 through 5,
hinting the presence of the enzymes that utilize this mannose donor for the
synthesis of PIMs in these fractions (Fig. 3.1D).
To compare the appearance of the IMD with that of the PM-CW, we
precipitated these membrane fractions using differential centrifugation and
visualized by negative staining electron microscopy (Fig. 3.1E). Clear differences
were observed between these membranes. As observed in M. smegmatis (Morita el
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Figure 3.1. Evidence of membrane compartmentalization in M. tuberculosis.
A. Sucrose gradient density fractionation of attenuated M. tuberculosis strain. The
sucrose density and protein concentration of the fractions are shown to ensure
proper gradient formation. B. Western blot detection of cytosol marker Ino1 (40
kDa) and PM-CW marker Rv2181 (47 kDa). C. CL and PI are present in both the IMD
and PM-CW while PE is detected mainly in the PM-CW as seen by molybdenum blue
staining. PIMs distribution show presence of monoacylated PIM species (AcPIM2
and AcPIM6) in both IMD and PM-CW, and diacylated species (Ac2PIM2 and
Ac2PIM6) present only in the PM-CW fractions as detected by orcinol staining. D.
PPM formation detection in the IMD after incorporation of GDP-[3H]-Mannose. E.
Electron microscopy of the IMD and PM-CW fractions.
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at, 2005), the IMD contained small vesicle-like structures, while the PM-CW fraction
revealed larger fragments of cells. Together, these data support evidence that the
IMD is present in M. tuberculosis with characteristics similar to M. smegmatis.

3.3.2 Identification of IMD-associated proteins in M. tuberculosis
To identify proteins that are located in the IMD more comprehensively, we
used differential centrifugation to precipitate the membranes in both IMD and PMCW fractions and performed proteomic analysis. The proteomes of both membranes
were distinct with numerous similarities to the proteomes of M. smegmatis IMD and
PM-CW (Hayashi et al, 2016). A total of 555 and 756 proteins were identified as
being enriched by a 2-fold change in the PM-CW and IMD respectively (Fig. 3.2A,
Dataset S1). A variety of functions were assigned to the proteins present in the PMCW, which is consistent with a classical plasma membrane (Fig. 3.2B). More
specifically, we identified proteins involved in the electron transport chain, such as
the NADH-quinone oxidoreductase subunits K-N (Rv3145-3158), secretion system,
such as EccB5-E5 (Rv1782, Rv1783, Rv1795, Rv1797), and lipid transport, such as
MmpL3 (Rv0206c), MmpL7 (Rv2942), and MmpL8 (Rv3823). The IMD, on the other
hand, seemed to be more restricted in functionalities associated with metabolism
involving lipids (Fig 3.2B). For instance, the galactofurosyltransferase GlfT2
(Rv3808c) involved in arabinogalactan biosynthesis, and the mannosyltransferase
PimB’ (Rv2188c) involved in PIMs biosynthesis were enriched in the IMD, as well as
acyl-CoA dehydrogenases FadE24 (Rv3139), FadE23 (Rv3140), and FadE10
(Rv0873). From the total of 756 proteins identified in the IMD through the
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comparative proteomics, 564 had M. smegmatis homologues. Of these, 118 have also
been identified previously as enriched in the IMD of M. smegmatis when compared
to the PM-CW, with 57 confirmed as IMD-associated proteins by refined proteomic
analysis (Dataset S1) (Hayashi et al, 2016). Furthermore, 47 proteins identified here
were only detected by the refined proteomics in M. smegmatis. Fifty-eight proteins
were previously found in the PM-CW and the remaining 341 were not found in the
comparative proteomic analysis of M. smegmatis.

3.3.3 Validation of IMD-associated proteins
Among the IMD proteins, we identified the dihydroorotate dehydrogenase
PyrD, which is involved in pyrimidine biosynthesis and is dependent on a lipidic
electron carrier, menaquinone, for the redox reaction (Björnberg et al,. 1997,
Munier-Lehmann et al, 2013). This protein has been biochemically confirmed to be
an IMD-associated protein in M. smegmatis (Hayashi et al, 2016). We chose this
protein for the biochemical validation of the M. tuberculosis IMD proteome. We
cloned the gene with a hemagglutinin (HA) epitope tag into an expression vector,
integrated into the bacteriophage L5 integration site of M. tuberculosis genome, and
confirmed its expected molecular weight of 38 kDa (Fig. 3.3A). We then fractionated
the cell lysate by sucrose density gradient fractionation, confirmed the gradient by
refractive index and the enrichment of cytoplasmic proteins in the top fractions by
the BCA assay (Fig. 3.3B). We also confirmed the PM-CW fractions by western
blotting using anti-MptC antibody. We then detected the PyrD-HA localization using
an anti-HA antibody and revealed that this protein localizes to the fractions 3-5
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Figure 3.2. Proteome of the PM-CW and IMD.
A. Volcano plot of fragments detected in the IMD and PM-CW. Fragments were
detected and plotted based on fold-change and statistical significance in the IMD
versus the PM-CW, using paired samples (N=4). The horizontal dashed line
indicated P < 0.05 (Benjamini-Hochberg corrected P value). B. Distribution of
protein functions in the IMD and PM-CW. Protein function categorization of the
comparative proteome generated by the DAVID gene functional classification tool.
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corresponding to the expected density of the IMD (Fig. 3.3C). These data suggest
that PyrD associates with the IMD in M. tuberculosis as suggested by the
comparative proteomics.
To confirm further, we took advantage of the PyrD-HA-expressing strain and
performed a vesicle immunoprecipitation assay to pull down the IMD vesicles from
the IMD fraction using anti-HA agarose beads. We used the IMD fraction from the
parental strain as a negative control. With a cutoff of 5-fold change between the
experimental and negative control samples, 215 proteins were identified in the IMD
of M. tuberculosis (Dataset S1). Among them, 135 proteins were found in the IMD
proteome of the initial comparative proteomics. Out of these 215
immunoprecipitated proteins, 148 had M. smegmatis homologues, with 73 localizing
in the IMD of both species. Twenty-seven proteins found in the IMD of M.
tuberculosis, however, were previously discovered to be in the PM-CW of M.
smegmatis, and 48 were not found in the previous proteomic analysis or not
confirmed to be associated with the IMD in the refined proteomic analysis.
Interestingly, a group of 67 proteins unique to M. tuberculosis were also found to be
enriched in the IMD, including proteins involved in the biosynthesis of phthiocerol
dimycocerosate (PDIM). These data support the hypothesis that the IMD is a
conserved domain within mycobacteria with unique features associated with each
species.
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Figure 3.3. Integrative expression PyrD-HA shows localization to the IMD.
A. Western blot of the crude lysate of attenuated M. tuberculosis PyrD-HAStr strain for
detection of recombinant PyrD-HA (39 kDa). B. Sucrose density and protein
concentration for each fraction were determined to ensure proper gradient
formation. C. Western blot detection of PyrD-HA (39 kDa) in the IMD fractions and
the PM-CW marker Rv2181 (47 kDa).
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3.3.4 Visualization of IMD proteins in M. tuberculosis
To visualize the IMD in M. tuberculosis, we constructed a mutant, in which a
gene encoding 2xHA-tagRFP tag was knocked into the 3’ end of the endogenous
pyrD gene locus. The in-frame insertion was designed to produce a PyrD-2xHAtagRFP fusion protein from the endogenous locus using endogenous promoter. This
mutant was grown to log phase, and cell lysate was fractionated by sucrose density
gradient. We detected the localization of this fusion protein to the IMD by western
blotting using anti-HA antibody (Fig. 3.4), while the PM-CW marker MptC was
detected in the denser density fractions. When we examined this strain by live
fluorescence microscopy, we were unable to detect the fluorescence, possibly due to
low abundance of the protein expressed from the endogenous promoter.
To visualize the IMD in live M. tuberculosis cells, we took an alternative
approach of integrating an expression vector at the mycobacteriophage L5 attB site
and expressing another IMD-associated protein as a fluorescent protein fusion using
a strong promoter. We chose Psd, a phosphatidylserine decarboxylase enzyme
involved in the PE biosynthesis, whose presence and activity were previously shown
to be enriched in the IMD of M. smegmatis (Morita et al, 2005; Hayashi et al, 2016).
We first constructed an expression vector for Psd-mNeonGreen-HA and performed a
sucrose gradient fractionation of the crude cell lysate to biochemically validate the
IMD-association. After confirming the proper gradient formation (Fig. 3.5A)
localization of the tagged protein was successfully detected to the IMD fractions
(Fig. 3.5B), with Rv2181 determining the PM-CW fractions. We analyzed the
localization in live cells by super-resolution fluorescence microscopy and found
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Figure 4
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Figure 3.4. Endogenous expression of PyrD-2xHA-tagRFP shows association
with the IMD.
A. Sucrose gradient density fractionation of attenuated M. tuberculosis PyrD-2xHAtagRFP strain. Sucrose density and protein concentration for each fraction were
determined to ensure proper gradient formation. B. Western blot detection of PyrD2xHA-tagRFP (64 kDa) in the IMD fractions and the PM-CW marker Rv2181 (47
kDa).
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Figure 3.5. Integrative expression Psd-mNeonGreen-HA shows association to
the IMD.
A. Sucrose gradient density fractionation of attenuated M. tuberculosis Psd-HAKan
strain. Sucrose density and protein concentration for each fraction were determined
to ensure proper gradient formation. B. Western blot detection of Psd-mNeonGreenHA (50 kDa) in the IMD fractions and the PM-CW marker Rv2181 (47 kDa). C.
Fluorescence microscopy of mNeonGreen showing polar and patchy pattern.
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punctuated pattern with subpolar foci consistent with the IMD (Fig. 3.5C), being
similar to the patterns observed in M. smegmatis.

3.4 Discussion
The concept of subpolar organization for cell elongation has been
demonstrated in M. smegmatis (Meniche et al, 2014; Hayashi et al 2016), and the
IMD has been shown to be a dynamic entity with diverse functions (Hayashi 2016,
2018). Here, we demonstrate the existence of such organization in growing M.
tuberculosis, evidenced by biochemical assays and live imaging. Through
comparative proteomics, we determined the diversity of functions associated with
the IMD, presenting conserved features of this domain between M. tuberculosis and
M. smegmatis.
Through sucrose gradient fractionation of M. tuberculosis different
components were identified in each fraction. First, we could determine cytosolic
fractions by the enrichment of total proteins and the presence of a cytosolic proteins
present in the first two fractions of the gradient. Next, the presence of the
mannosyltransferase MptC to the later fractions of the gradient is consistent with
what is found in M. smegmatis, designating these as PM-CW fractions (Hayashi et al,
2016). The lipid distribution, as seen by the detection of CL, PE, PI, was also
consistent with what is seen in the sucrose gradient fractionation of M. smegmatis,
where these lipid species are distributed among the fractions (Morita et al, 2005;
Hayashi et al, 2016). Furthermore, the enrichment in monoacyl PIM species, but not
of diacyl PIM species, and incorporation of radiolabeled mannose into this
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biosynthesis, allude to the notion the initial products of PIMs can be formed and
present in the IMD, however there could be exclusive enzymes present in the PMCW that allow the formation of these more complex species.
The comparative proteome analysis between the PM-CW and IMD, and
further refined IMD proteome, showed distinct functions assigned to each of these
domains. The PM-CW proteome adds to our hypothesis that these fractions are
consistent with a classical plasma membrane. Fundamentally, much like the M.
smegmatis PM-CW, M. tuberculosis PM-CW was enriched in proteins involved in cell
wall synthesis, one example being DivIVA (Rv2145c). DivIVA phosphorylation by
the Ser/Thr protein kinases, PknA and PknB, have been demonstrated to be
important for determination of the cell site of growth (Jani et al, 2010). In our
proteomic analysis, both PknA and PknB were enriched in the PM-CW, agreeing
with the suggestion that these proteins co-localize with DivIVA in order to
phosphorylate proteins involved in cell elongation, including DivIVA (Kang et al,
2008). Many proteins involved in biosynthetic reactions that are crucial for cell
growth were found in the M. tuberculosis IMD proteome, similar to M. smegmatis.
GlfT1 (Rv3782) and GlfT2 (3808), involved in arabinogalactan biosynthesis, and
PimB (Rv2188c) involved in PIMs biosynthesis were enriched in the M. tuberculosis
IMD, supporting the hypothesis that the IMD is a growth-related domain (Hayashi et
al, 2016; Morita et al 2005).
As mentioned above, proteins involved in the electron transport chain were
found among those identified in the PM-CW, which is consistent with previously
described in M. smegmatis (Hayashi et al, 2016). However, we recently reported that
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the biosynthetic reaction for menaquinone biosynthesis, the main lipoquinone
present in mycobacteria, is divided between the IMD and PM-CW in M. smegmatis
(Puffal et al, in press). Here, we identified the same demethylmenaquinone
methyltransferase MenG (Rv0558), and the menaquinone reductase MenJ
(Rv0561c) present in the refined proteomic analysis of the IMD. This may suggest
the presence of menaquinone in the IMD as well, and support the idea that PyrD can
utilize this quinone as an electron acceptor in the IMD.
Overall the IMD proteome of both species harbor conserved reactions. The
co-localization of 73 homologues showed the conserved function of the IMD
involving lipid metabolism. The identification of Psd (Rv0437c) as a common
protein between the species adds to this point. The further characterization of this
protein localization in live growing cells, confirms the conservation in subcellular
localization of the IMD, with foci associated with the growing poles.
Besides the conserved features of the IMD, we also identified unique IMDassociated proteins in M. tuberculosis. Of note, more lipid metabolism proteins were
found, specially polyketide synthases (Pks). First, we detected Pks13, which
catalyzes the condensation of two fatty acids which are reduced by CmrA in the
cytosol to form mycolic acid (Lea-Smith et al, 2007; Portevin et al, 2004). This
protein has previously been observed in the subpolar region of M. smegmatis,
interacting with FadD32 (Meniche et al, 2014). Another group of Pks identified in
our proteome analysis was associated with the phthiocerol biosynthesis: ppsA-E
(Rv2931-2935). PpsE, the last enzyme in the phthiocerol biosynthesis, has been
shown to interact with the PDIM transporter MmpL7 (Rv2942) (Jain et al, 2005),
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and interestingly this protein was found in our PM-CW proteome analysis. This
might suggest another biosynthetic reaction divided between the IMD and PM-CW
likely for the coordination of synthese and transport of PDIM.
Furthermore, there were some proteins identified in our proteomic analysis
of the IMD that have been previously identified as associated with M. smegmatis PMCW (Hayashi et al, 2016). Pks13 is one of these proteins. The data shown here with
the previous visualization of Pks13 enriched in the subpolar region of the cell
(Meniche et al, 2014) could support the IMD association, but further studies need to
be done to validate such interaction. Another protein previously identified as PMCW through proteomics but identified in our analysis in the IMD was a succinate
dehydrogenase (Rv0248c). It is unlikely for such protein to be associate with the
IMD, given its electron carrier nature. However, other electron transport
components have been found in the IMD of M. smegmatis (Hayashi et al, 2016; Puffal
et al, in press), and this observation could potentially bring attention to another
function of the IMD.
Together, these data suggest that the IMD is a conserved domain enriched in
lipid metabolism reactions. The biochemical and microscopic assays reveal
differences between the IMD and PM-CW fractions in M. tuberculosis, in terms of
proteins and lipids, that was previously observed in M. smegmatis. Therefore,
suggest that the IMD is a conserved growth pole associated membrane domain
found in the genus Mycobacterium.
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CHAPTER 4
DISCUSSION
The polar growth of mycobacteria is a key field of research currently under
rapid investigation. The coordinated assembly of the complex cell envelope during
growth require fine organization within the cells. Understanding how these
processes are organized and how mycobacteria starts growth is important because
the treatment of mycobacterial diseases often relies on the pathogen’s active
growth.
In chapter 1, we describe a comprehensive review of what is known about
the processes that require specific subcellular localization within the mycobacterial
cell. For the remaining of the work presented, we focus on the membrane domain,
the IMD, a dynamic spatially distinct membrane associated with the growing pole.
This domain is still under investigation in M. smegmatis, however, we know that the
IMD is a metabolically active domain that harbors a variety of different reactions. A
major part of these are associated with lipid metabolism and involved in the
formation of cell envelope lipids. On chapter 2, we characterize another reaction
associated with the IMD, the menaquinone biosynthesis. Menaquinone is the major
lipoquinone in mycobacteria, playing a crucial role in cellular respiration. Its
synthesis in the IMD was shown to be essential for the survival of the bacteria.
Moreover, the reasoning for the presence of this quinone in the IMD is still unknown
but shines light on the idea that the IMD can be involved in the central metabolism
of M. smegmatis.
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Lastly, we identified the presence of the IMD in M. tuberculosis. Through
biochemical and proteome analysis we confirmed similarities between the IMD of M.
tuberculosis and M. smegmatis, with conservation of lipid metabolism reactions and
subcellular localization in live cells for instance. A recent study reported that the
IMD is re-distributed when M. smegmatis are not under optimal growth conditions.
What is the implication of this observation to M. tuberculosis? This pathogen is
known to enter a dormancy phase that can last for a long period of time. Analyzing
the IMD under these conditions and evaluating the behavior of this domain could
give insights to what are the cues that make the cells get out of dormancy and cause
active disease.
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APPENDIX A
MYCOBACTERIUM SMEGMATIS IMD DURING STARVATION
Recent data from our research group has demonstrated that when in
stationary phase or under stress caused by starvation, the IMD reorganizes and is
distributed along the column of the cell rather than the polar ends (Hayashi et al,
2018). That was an interesting observation suggesting that the IMD is active during
growth and changes depending on the physiologic state of the cell. Therefore, we
decided to investigate the protein content of the IMD under stress, comparing to log
phase.
For that, we used two Mycobacterium smegmatis strains: wild type (Msmeg)
and a reporter strain expressing the galactosyltransferase GlfT2 tagged with HAmCherry at the N-terminus, HA-mCherry-GlfT2 (Msmeg-HA) (SUMA086). We
performed sucrose gradient fractionation of the two strains in log phase as well as
after 6 hours of mild starvation in PBS with 0.05% Tween 80. The fractions
containing the IMD from each experiment were pooled together to obtain four
samples: Msmeg_log, Msmeg_starv, Msmeg-HA_log, and Msmeg-HA_starv. We coimmunoprecipitated the samples using anti-HA agarose beads and performed
proteomic analysis to determine the protein differences between log phase and
starvation condition. The Msmeg_log, and Msmeg_starv samples were used to
determine the pull down of non-specific proteins. The detailed protocols are found
in the Laboratory Notebook Puffal #8, pages 144-147, and #9, pages 5-25.
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To start analyzing the proteome of the IMD under starvation, we compared
Msmeg-HA_log against Msmeg_log, and Msmeg-HA_starv against Msmeg_starv. A
total of 325 proteins were detected in log phase versus 249 under starvation with a
2-fold change cutoff from the mock. Our analysis detected 117 enriched in the IMD
in log phase (Table A1) and 132 under starvation (Table A2) when both conditions
were compared with a 2-fold change cutoff.
A preliminary analysis of this proteome revealed that out of the 117 proteins
found enriched in the IMD in log phase, 59 were previously found in this membrane
domain while 8 were previously found in the PM-CW (Table A1) (Hayashi et al,
2016). Under starvation, 18 proteins were previously found in the IMD and 13 in the
PM-CW (Table A2). Using DAVID Bioinformatics Resources 6.8 we classified the
proteins found into functional groups. We saw similar functionalities as previously
described in the IMD of log phase cells (Hayashi et al, 2016). Most were part of
carbohydrates and lipid metabolism, and cell wall biogenesis (Fig A1A). Under
starvation we still identified major functional groups as seen in log phase, however,
distinct groups appear, such as signal transduction and transcription (Fig A1B)
Discussion
This preliminary analysis of the IMD of cells under starvation suggest that its
proteome can be remodeled as is its localization in live cells. The appearance of
regulatory proteins in the IMD of cells under starvation is of interest because such
proteins could be important for the redistribution of the IMD along the cell under
stress. It would be interesting to investigate more about the potential role of these
proteins in the IMD.
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#
1
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MSMEI
0095
0105

MSMEG_
0098
0109

3
4
5
6

0106
0304
0579
0610
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0311
0595
0625

7
8
9
10
11
12

0625
0673
0755
0816

0641
0690
0771
0806
0816
0835

13

0884

0905

14
15

0933
0941

0959
0967

16

0944

0970

17
18
19

1083
1160
1177

1115
1191
1211

20
21
22
23

1307
1391
-

1345
1426
1456
1499

24
25

1616
-

1655
1699

26
27
28
29

1846
1879

1738
1743
1886
1920

30
31
32
33
34
35
36

2065
2077
2105
2205
2365

1937
2108
2112
2125
2157
2261
2426

37
38

2457
2523

2517
2585

39

2707

2776

40
41
42

2860
2982

2934
3039
3058

43
44
45
46
47
48

3070
3355
-

3151
3318
3434
3621
3675
3764

Proteins
Methyltransferase
NAD(P) transhydrogenase subunit beta
NAD(P) transhydrogenase, alpha
subunit
Glycosyltransferase
Glycolate oxidase
Uncharacterized protein
Binding-protein-dependent transport
systems inner membrane component
Iron-sulfur cluster-binding protein
Putative oxidoreductase YqjQ
Hydrolase
Flavin-binding monooxygenase
Superoxide dismutase [Cu-Zn]
4-carboxymuconolactone
decarboxylase domain protein
Putative conserved transmembrane
protein
Uncharacterized protein
Phosphoglycerate mutase family
protein
Demethylmenaquinone
methyltransferase
Uncharacterized protein
Fatty acid desaturase
Transcription
termination/antitermination protein
NusG
Probable membrane sugar transferase
Uncharacterized protein
Oxygenase
Hydrolase, alpha/beta fold family
protein, putative
Pentachlorophenol 4-monooxygenase
Probable conserved transmembrane
protein
Fatty acid desaturase
Fatty acid desaturase
Diacylglycerol kinase, catalytic region
Molybdopterin biosynthesis protein
MoeB
Uncharacterized protein
Secreted protein
Glycerol operon regulatory protein
Uncharacterized protein
Uncharacterized protein
Nitrogen regulatory protein P-II
Hydrolase, alpha/beta fold family
protein, putative
Uncharacterized protein
1-deoxy-D-xylulose-5-phosphate
synthase
Phosphatidylinositol mannoside
acyltransferase
Monooxygenase
Lipoprotein
Enoyl-[acyl-carrier-protein] reductase
[NADH]
Oxidoreductase
Peptidyl-prolyl cis-trans isomerase
NADH dehydrogenase
Metal-dependent hydrolase
Uncharacterized protein
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Accession Number
AFP36577.1
ABK73265.1

M. W.
25 kDa
50 kDa

Fold Change
95% (2.4)
95% (2.2)

WP_011726673.1
YP_884725.1
AFP37060.1
AFP37091.1

53 kDa
43 kDa
26 kDa
45 kDa

95% (3.5)
95% (INF)
95% (2.1)
95% (2.5)

YP_885051.1
ABK73825.1
WP_003892195.1
ABK70355.1 (+1)
AIU06076.1
YP_885239.1

35 kDa
111 kDa
30 kDa
53 kDa
56 kDa
23 kDa

95% (INF)
95% (19)
95% (2.9)
95% (INF)
95% (15)
95% (3.1)

AFP37364.1 (+1)

21 kDa

0% (2.0)

AFP37413.1
ABK70956.1

18 kDa
14 kDa

95% (INF)
0% (2.0)

AFP37424.1 (+1)

23 kDa

95% (6.1)

WP_011727422.1
AFP37636.1
YP_885603.1

25 kDa
8 kDa
41 kDa

95% (2.1)
95% (2.7)
95% (13)

YP_885732.1
WP_011727662.1
WP_011727682.1
AIU06734.1

30 kDa
50 kDa
61 kDa
54 kDa

95% (INF)
95% (3.1)
95% (20)
95% (3.9)

AFP38088.1
AIU06929.1

31 kDa
41 kDa

95% (2.4)
95% (22)

AIU06964.1
ABK75848.1
YP_886252.1
WP_011728010.1

21 kDa
43 kDa
48 kDa
34 kDa

95% (5.9)
95% (INF)
95% (410)
95% (4.0)

WP_011728025.1 (+1)
AIU07315.1
AFP38536.1
AFP38548.1 (+1)
AFP38575.1
AFP38675.1
AFP38833.1

43 kDa
35 kDa
20 kDa
26 kDa
32 kDa
21 kDa
12 kDa

95% (INF)
95% (INF)
95% (INF)
95% (INF)
95% (INF)
95% (INF)
95% (INF)

AFP38925.1
AFP38991.1

32 kDa
21 kDa

95% (2.7)
95% (INF)

YP_887107.1

68 kDa

95% (3.2)

WP_011728702.1
AIU08196.1
YP_887374.1

34 kDa
44 kDa
31 kDa

95% (INF)
95% (INF)
95% (5.2)

YP_887466.1
AIU08463.1
AFP39818.1 (+1)
AIU08755.1
AIU08808.1
AIU08886.1

29 kDa
45 kDa
11 kDa
49 kDa
34 kDa
8 kDa

95% (41)
95% (3.9)
95% (INF)
95% (5.3)
95% (2.9)
95% (INF)

49
50

3764

3832
3855

51

-

3859

52
53
54

4152
4183

3887
4252
4284

55
56
57
58
59
60
61
62
63
64
65

4226
4341
4447
4612
4632
-

4326
4335
4451
4479
4558
4560
4578
4729
4752
5017
5030

66
67
68
69
70
71
72
73

4996
5004
5039
5144
5230
5351

5069
5124
5136
5173
5283
5310
5376
5505

74
75
76
77

5391
5532
-

5544
5682
5767
5784

78

-

5799

79
80
81
82
83

5722
5781
5810
5902

5881
5941
5969
5998
6062

84

6217

6385

85
86
87
88
89
90
91
92

6235
6241
6330
6386
6567
-

6402
6403
6409
6502
6563
6749
6793
6811

93
94

96

0380
0980
2231
0998
2249

97
98

1795

6944
0387
1009
2289
1028
2308
1055
2335
1837

95

4-hydroxyacetophenone
monooxygenase
Uncharacterized protein
Polyprenol monophosphomannose
synthase
Sec-independent protein translocase
protein TatA
Uncharacterized protein
Uncharacterized protein
Meromycolate extension acyl carrier
protein
Uncharacterized protein
Probable monooxygenase
Uncharacterized protein
Uncharacterized protein
Periplasmic binding protein
Diglucosylglycerate octanoyltransferase
Uncharacterized protein
Uncharacterized protein
Lipoprotein
Uncharacterized protein
Sec-independent protein translocase
protein TatB
2,4-dienoyl-coA reductase
Helix-turn-helix motif
O-methyltransferase, putative
Hydrolase, CocE/NonD family protein
SAM-dependent methyltransferase
Uncharacterized protein
Uncharacterized protein
Oxidoreductase, short chain
dehydrogenase/reductase family
protein
Uncharacterized protein
Uncharacterized protein
Transcriptional regulatory protein
Nucleoside-diphosphate-sugar
epimerase
Putative carbon monoxide
dehydrogenase subunit G
3-oxosteroid 1-dehydrogenase
Uncharacterized protein
Uncharacterized protein
Fe uptake system permease
Decaprenylphosphoryl-2-keto-beta-Derythro-pentose reductase
Putative decaprenylphosphoryl-5phosphoribose phosphatase
MSMEG_6402
Galactofuranosyltransferase GlfT2
Acyltransferase family protein
Uncharacterized protein
Dihydrokaempferol 4-reductase
Uncharacterized protein
Uncharacterized protein
Uncharacterized protein
Putative membrane protein insertion
efficiency factor
Rmt2 protein

AIU08949.1
AFP40222.1

54 kDa
27 kDa

95% (5.2)
95% (2.1)

A0QZ12

29 kDa

95% (4.3)

AAY44411.1
YP_888529.1
WP_011729703.1

12 kDa
14 kDa
32 kDa

95% (2.3)
95% (5.1)
95% (6.0)

ABK73710.1
WP_042510657.1 (+1)
YP_888725.1
WP_003895835.1
WP_011729921.1
YP_888831.1
AIU09647.1
ABK70957.1
AFP41081.1
ABK74067.1 (+1)
AIU10068.1

11 kDa
31 kDa
63 kDa
10 kDa
24 kDa
36 kDa
28 kDa
50 kDa
10 kDa
22 kDa
17 kDa

95% (8.0)
95% (INF)
95% (INF)
95% (9.9)
95% (INF)
95% (INF)
95% (4.0)
95% (INF)
95% (4.1)
95% (3.4)
95% (2.2)

AIU10107.1
ABK73847.1
YP_889382.1
ABK71038.1
WP_014878283.1
AIU10339.1
AFP41674.1
AFP41792.1

15 kDa
73 kDa
17 kDa
31 kDa
63 kDa
29 kDa
14 kDa
21 kDa

95% (7.2)
95% (8.6)
95% (INF)
95% (15)
95% (2.5)
95% (6.5)
95% (8.0)
95% (3.5)

AFP41832.1
WP_003897094.1
ABK76029.1 (+1)
ABK70198.1 (+1)

27 kDa
40 kDa
39 kDa
38 kDa

95% (13)
95% (2.2)
95% (3.8)
95% (3.5)

YP_890027.1

50 kDa

95% (INF)

ABK75316.1
AFP42214.1 (+1)
WP_011730934.1
AIU10997.1
YP_890284.1

24 kDa
61 kDa
46 kDa
18 kDa
28 kDa

95% (7.4)
95% (3.3)
95% (3.2)
95% (INF)
95% (INF)

AFP42643.1

27 kDa

95% (3.3)

WP_003897811.1
YP_890616.1
YP_890622.1
WP_011731324.1
ABK70188.1
AFP42993.1 (+1)
YP_891001.1
AIU11775.1

18 kDa
72 kDa
29 kDa
15 kDa
37 kDa
9 kDa
52 kDa
45 kDa

95% (3.8)
95% (2.6)
95% (2.1)
95% (INF)
95% (3.2)
95% (7.6)
95% (5.5)
95% (INF)

YP_891136.1
ABB72067.1

13 kDa
35 kDa

95% (INF)
95% (3.0)

Cytochrome p450

ABK73406.1

56 kDa

95% (2.1)

Geranylgeranyl reductase

ABK69691.1

43 kDa

95% (2.0)

Hexapeptide transferase family protein
Secreted protein

YP_886681.1
AFP38267.1

28 kDa
50 kDa

95% (3.2)
95% (2.4)
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99

3573

3660

100
101

-

-

102

5222

-

103

6142

-

104

-

-

105
106
107

0303
0935

-

108

-

-

109
110

5664

-

111

-

-

112
113

2677

-

114

6302

-

115
116

5807
6409

-

117

-

-

Uncharacterized protein
Iron ABC transporter, periplasmic ironbinding protein
Uncharacterized protein
Ectoine/hydroxyEctoine ABC
transporter solute-binding protein
ABC amino acid transporter, permease
component
AIU10799.1 hypothetical protein
LJ00_28630 [Mycobacterium
smegmatis str. MC2 155]
AIU10299.1 acyl-CoA dehydrogenase
[Mycobacterium smegmatis str. MC2
155]
Putative methyltransferase
Uncharacterized protein
Cluster of 4RSM_C Chain C, Crystal
Structure Of Carbohydrate Transporter
Msmeg_3599 From Mycobacterium
Smegmatis Str. Mc2 155, Target Efi510970, In Complex With D-threitol
(4RSM_C)
AIU08831.1 NAD-dependent epimerase
[Mycobacterium smegmatis str. MC2
155]
Abortive infection protein
AIU08517.1 choline dehydrogenase
[Mycobacterium smegmatis str. MC2
155]
5CYU_A Chain A, Structure Of The
Soluble Domain Of Eccb1 From The
Mycobacterium Smegmatis Esx-1
Secretion System.
Alpha/beta hydrolase fold protein
NAD-dependent
epimerase/dehydratase
WP_014878510.1 glucose-methanolcholine oxidoreductase
[Mycobacterium smegmatis]
Fumarylacetoacetate (FAA) hydrolase
WP_029104121.1 hydrolase
[Mycobacterium smegmatis]

AFP40036.1

21 kDa

95% (2.3)

AIU08770.1
AIU05861.1

36 kDa
21 kDa

95% (INF)
95% (INF)

AFP41666.1 (+1)

32 kDa

95% (INF)

AFP42572.1 (+1)

53 kDa

95% (INF)

AIU10799.1

10 kDa

95% (INF)

AIU10299.1 (+1)
WP_014876733.1
AFP37415.1

41 kDa
28 kDa
34 kDa

95% (INF)
95% (6.1)
95% (5.5)

4RSM_C [4]

34 kDa

95% (4.7)

AIU08831.1
AFP42099.1 (+1)

30 kDa
22 kDa

95% (4.2)
95% (3.7)

AIU08517.1

62 kDa

95% (3.5)

5CYU_A (+1)
AFP39145.1

43 kDa
32 kDa

95% (3.3)
95% (2.9)

AFP42728.1

38 kDa

95% (2.8)

WP_014878510.1 (+1)
AFP42835.1 (+1)

58 kDa
35 kDa

95% (2.6)
95% (2.5)

WP_029104121.1

30 kDa

95% (2.1)

Table A1. Proteins enriched in the IMD during log phase.
Highlighted in green are the proteins found previously in the IMD and in orange the
ones found in the PM-CW (Hayashi et al, 2016).
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#
1

MSMEI
-

MSMEG
0033

2
3
4
5
6
7
8

0116
0216
0273
0378
0535
0653

0120
0223
0280
0363
0385
0550
0669

9

0654

0671

10
11

0777

0696
0793

12

0790

0809

13
14
15
16

0861
0888
0901
0911

0882
0909
0923
0934

17
18
19
20
21
22

0943
1143
1220
-

0969
1076
1131
1174
1255
1321

23
24
25
26

1307
1439
1455
1465

1345
1475
1491
1501

27
28

1481
-

1517
1543

29
30
31
32
33

1529
1641
1778
1890

1566
1682
1775
1821
1931

34
35
36
37
38

1936
2020
2025
2065

1937
1980
2065
2070
2112

39
40
41
42
43
44
45

2105
2287

2116
2157
2159
2343
2344
2346
2347

46
47
48
49

2480
2846

2351
2391
2540
2919

Proteins
Protein phosphatase 2C
Transcriptional regulatory protein
(Possibly TetR-family)
Uncharacterized protein
Alpha/beta hydrolase fold
TetR-family protein regulatory protein
Glycosyl transferase family 1
Sulfonate binding protein
Uncharacterized protein
S-(Hydroxymethyl)glutathione
dehydrogenase

Accession Number
AIU05317.1

M. W.
53 kDa

Fold Change
95% (INF)

AFP36598.1
YP_884638.1
WP_011726805.1
ABK69655.1 (+1)
AIU05662.1
YP_884961.1
AFP37134.1

25 kDa
18 kDa
32 kDa
23 kDa
46 kDa
35 kDa
21 kDa

95% (INF)
95% (INF)
95% (3.1)
95% (INF)
95% (3.8)
0% (2.0)
95% (INF)

YP_885080.1

41 kDa

95% (INF)
95% (INF)

Alanine-rich protein
Thiazole synthase
Isoprenylcysteine carboxyl
methyltransferase
Pyridoxamine 5'-phosphate oxidaserelated, FMN-binding protein
Acyl-ACP thioesterase
Uncharacterized protein
Uncharacterized protein
Glutamate-1-semialdehyde 2,1aminomutase
Uncharacterized protein
Tryptophan-rich sensory protein
Cadmium inducible protein cadi
DNA helicase
Alanine-rich protein
Transcription
termination/antitermination protein
NusG
Uncharacterized protein
Histidinol-phosphate aminotransferase
O-methyltransferase
Spfh domain/band 7 family protein,
putative
Eptc-inducible aldehyde dehydrogenase
LLM class F420-dependent
oxidoreductase
Flavin-containing monooxygenase FMO
Cytochrome P450 monooxygenase
Acyl-CoA dehydrogenase
Uncharacterized protein
Molybdopterin biosynthesis protein
MoeB
Putative oxidoreductase
YceI like family protein
Acyl-CoA dehydrogenase family protein
Secreted protein
PTS system, glucose-specific IIBC
component
Uncharacterized protein
Uncharacterized protein
Methylesterase
Dehydrogenase
Phytoene synthase
Phytoene dehydrogenase
Electron transfer flavoprotein, beta
subunit
Polyphosphate kinase
Uridylate kinase
2-dehydropantoate 2-reductase

AIU05960.1
A0QQL0.1

12 kDa
26 kDa

95% (INF)

AFP37270.1

18 kDa

95% (INF)

AFP37341.1
AFP37368.1 (+1)
ABK72090.1
YP_885337.1

14 kDa
31 kDa
33 kDa
19 kDa

95% (INF)
95% (INF)
95% (INF)
95% (INF)

AFP37423.1 (+1)
ABK73780.1 (+1)
ABK75873.1
ABK73980.1
AFP37696.1
AIU06599.1

47 kDa
10 kDa
17 kDa
16 kDa
81 kDa
27 kDa

95% (INF)
95% (INF)
95% (11)
95% (INF)
95% (INF)
95% (INF)

YP_885732.1
AFP37912.1
WP_014877088.1
AFP37938.1

30 kDa
33 kDa
38 kDa
33 kDa

95% (INF)
95% (INF)
95% (INF)
95% (5.3)

YP_885899.1
WP_011727729.1 [3]

55 kDa
56 kDa

95% (INF)
95% (INF)

WP_014877116.1 (+1)
YP_886058.1
AIU06998.1
YP_886192.1
YP_886297.1

37 kDa
46 kDa
50 kDa
42 kDa
25 kDa

95% (INF)
95% (2.5)
95% (INF)
95% (INF)
95% (INF)

WP_011728025.1 (+1)
AFP38407.1
ABK75727.1
ABK70133.1
AFP38536.1

43 kDa
43 kDa
18 kDa
47 kDa
20 kDa

95% (INF)
95% (7.9)
95% (INF)
95% (INF)
95% (INF)

ABK74482.1
AFP38575.1
ABK74074.1 (+1)
ABK74893.1 (+1)
WP_011728281.1 (+1)
AIU07531.1
ABK74949.1

56 kDa
32 kDa
31 kDa
38 kDa
55 kDa
35 kDa
56 kDa

95% (INF)
95% (INF)
95% (INF)
95% (230)
95% (INF)
95% (INF)
95% (INF)

AIU07536.1
ABK72018.1 (+1)
AFP38948.1
ABK69672.1

28 kDa
82 kDa
26 kDa
35 kDa

95% (14)
95% (INF)
95% (7.2)
95% (INF)
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50

2884

2958

51
52
53
54
55
56

2946
3019
-

2988
3021
3039
3097
3220
3255

57
58
59
60
61
62
63
64

3185
3193
3460
3680
4153
4159
-

3269
3278
3542
3706
3769
4254
4258
4485

65
66
67

4393
4472

4505
4558
4584

68

4538

4656

69
70
71

4575
4582

4673
4692
4699

72

4593

4710

73

4594

4711

74
75
76
77
78
79

4595
4598
4606
4836
4989

4712
4715
4723
4962
4990
5117

80
81
82
83
84
85
86
87
88
89

4990
5004
5088
5118
5132
5252
5254

5119
5136
5183
5225
5256
5271
5389
5400
5401
5402

90
91
92
93
94
95
96

5321
5336
5359
5403
5433
5489
5569

5471
5488
5511
5533
5582
5639
5721

97

-

5799

98

-

5884

99
100
101

5752
-

5912
5964
6082

Uncharacterized protein
Carbon-nitrogen hydrolase family
protein
AAA ATPase, central region
Monooxygenase
Phosphoenolpyruvate carboxylase
Tryptophan synthase beta chain
Uncharacterized protein
Putative sugar ABC transporter ATPbinding protein
Uncharacterized protein
Uncharacterized protein
Isocitrate lyase
Argininosuccinate lyase
AMP-binding enzyme
Anthranilate phosphoribosyltransferase
Glycine--tRNA ligase
Heat-inducible transcription repressor
HrcA
Uncharacterized protein
Gamma-glutamyl phosphate reductase
Sugar ABC transporter ATP-binding
protein
ATP-dependent Clp protease proteolytic
subunit
Uncharacterized protein
NAD-specific glutamate dehydrogenase
Dihydrolipoamide acetyltransferase
component of pyruvate dehydrogenase
complex
Pyruvate dehydrogenase E1 component
subunit beta
Pyruvate dehydrogenase E1 component,
alpha subunit
Acyl-CoA dehydrogenase
Uncharacterized protein
RemO protein
DNA-binding response regulator
Proline dehydrogenase
1-pyrroline-5-carboxylate
dehydrogenase
Uncharacterized protein
3-Hydroxyacyl-CoA dehydrogenase
Uncharacterized protein
(2Z,6E)-farnesyl diphosphate synthase
Esterase
LysA protein
Dehydrogenase
Uncharacterized protein
Dehydrogenase DhgA
Putative UTP--glucose-1-phosphate
uridylyltransferase
Response regulator MprA
von Willebrand factor type A
Uncharacterized protein
Uncharacterized protein
Enoyl-CoA hydratase
Acetyl-CoA acetyltransferase
Nucleoside-diphosphate-sugar
epimerase
3-hydroxyisobutyrate dehydrogenase
family protein
Putative succinate-semialdehyde
dehydrogenase [NADP(+)]
Glycosyl transferase, group 1, putative
Carbonic anhydrase
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YP_887277.1

25 kDa

95% (INF)

AIU08145.1
ABK75706.1
AIU08196.1
AFP39483.1
AFP39602.1
WP_029104319.1 [2]

33 kDa
47 kDa
44 kDa
103 kDa
45 kDa
31 kDa

95% (INF)
95% (INF)
95% (INF)
95% (INF)
95% (INF)
95% (71)

WP_011728939.1
AFP39656.1
ABK75729.1
AIU08833.1
WP_011729312.1
YP_888530.1
ABK71368.1 (+1)
AIU09558.1

40 kDa
13 kDa
13 kDa
85 kDa
50 kDa
64 kDa
38 kDa
52 kDa

95% (INF)
95% (2.1)
95% (11)
95% (INF)
95% (INF)
95% (INF)
95% (INF)
95% (INF)

WP_011729881.1
WP_011729921.1
ABK73874.1

37 kDa
24 kDa
44 kDa

95% (INF)
95% (INF)
95% (INF)

AFP40992.1

29 kDa

95% (14)

WP_003896047.1
AIU09748.1
AFP41034.1

22 kDa
16 kDa
178 kDa

95% (17)
95% (3.1)
95% (INF)

WP_011730028.1

43 kDa

95% (INF)

WP_011730029.1

39 kDa

95% (INF)

YP_888972.1
YP_888975.1
AFP41057.1 (+1)
ABK75543.1
ABK72654.1 (+1)
AFP41433.1

40 kDa
41 kDa
65 kDa
45 kDa
27 kDa
35 kDa

95% (INF)
95% (INF)
95% (INF)
95% (2.2)
95% (INF)
95% (INF)

AFP41434.1
YP_889382.1
AIU10218.1
YP_889471.1
WP_003896657.1
AFP41576.1 (+1)
ABK70402.1
AFP41695.1
ABK72860.1
ABK70329.1

58 kDa
17 kDa
26 kDa
22 kDa
30 kDa
37 kDa
25 kDa
56 kDa
18 kDa
28 kDa

95% (INF)
95% (INF)
95% (INF)
95% (INF)
95% (2.3)
95% (INF)
95% (INF)
95% (INF)
95% (INF)
95% (INF)

AFP41762.1
ABK75202.1 (+1)
AFP41800.1
AFP41844.1 (+1)
YP_889817.1
YP_889873.1
ABK72156.1

33 kDa
26 kDa
74 kDa
33 kDa
17 kDa
26 kDa
42 kDa

95% (INF)
95% (INF)
95% (35)
95% (INF)
95% (INF)
95% (INF)
95% (INF)

YP_890027.1

50 kDa

95% (INF)

AFP42159.1

30 kDa

95% (INF)

WP_003897308.1
ABK71444.1 (+1)
AIU11079.1

55 kDa
46 kDa
22 kDa

95% (2.1)
95% (4.1)
95% (15)

102
103
104

6052
6072

6097
6213
6233

105
106
107

6295
6301
6311

6467
6473
6483

108

6339

6511

109

6350

6524

110
111

6485

6616
6665

112

6558

6740

113

0993
2244
1009
2260
1016
2267
-

6804
1021
2301
1039
2319
1046
2326

114
115
116
117
118
119
120

0989
2240
6633

121
122
123
124

0253
2077
-

125
126

6285

127
128
129

3657
6243

130

-

131
132

5396
4872

Pantothenate synthetase
Manganese containing catalase
Uncharacterized protein
DNA protection during starvation
protein
O-methyltransferase-like protein
Methyltransferase type 11
Acyl-CoA dehydrogenase domain
protein
ABC Polyamine/Opine/Phosphonate
transporter, periplasmic ligand binding
protein
S-(Hydroxymethyl)glutathione
dehydrogenase
Integral membrane protein
1 aminocyclopropane-1-carboxylate
deaminase/D-cysteine desulfhydrase
family protein
Sugar ABC transporter substratebinding protein
Glyoxalase/bleomycin resistance
protein/dioxygenase

AIU11094.1
YP_890432.1
AFP42503.1

34 kDa
33 kDa
29 kDa

95% (INF)
95% (INF)
95% (INF)

A0R692.1
AFP42727.1
ABK75563.1

20 kDa
31 kDa
26 kDa

95% (INF)
95% (2.2)
95% (INF)

WP_011731330.1

42 kDa

95% (INF)

ABK71334.1

40 kDa

95% (8.8)

AIU11588.1
WP_003898066.1

42 kDa
10 kDa

95% (INF)
95% (180)

WP_003898118.1

36 kDa

95% (INF)

AIU11768.1

34 kDa

95% (INF)

ABK75589.1

15 kDa

95% (INF)

Periplasmic binding protein
ABC-type molybdenum transport
system, ATPase component
Uncharacterized protein
AIU07170.1 translation initiation factor,
IF2 family protein [Mycobacterium
smegmatis str. MC2 155]

AFP38730.1

37 kDa

95% (INF)

AFP38737.1
AIU11203.1

31 kDa
24 kDa

95% (INF)
95% (INF)

AIU07170.1 (+1)

24 kDa

95% (INF)

Protein nrdI
Regulatory protein MarR
AIU11110.1 D-alanyl-D-alanine
carboxypeptidase [Mycobacterium
smegmatis str. MC2 155]
Transcriptional regulator, XRE family
Transcriptional regulator IclR
Uncharacterized protein
AIU10299.1 acyl-CoA dehydrogenase
[Mycobacterium smegmatis str. MC2
155]
Luciferase-like protein
5EQD_A Chain A, Structure of Oxidized
Udp-galactopyranose Mutase from
Mycobacterium Smegmatis In Complex
with Udp In Opened And Closed Form
Uncharacterized protein
Uncharacterized protein
WP_003897810.1 decaprenyl-phosphate
phosphoribosyltransferase
[Mycobacterium smegmatis]
Conserved hypothetical membrane
protein
Alpha/beta hydrolase fold protein

AFP38710.1
AFP43059.1

12 kDa
17 kDa

95% (INF)
95% (INF)

AIU11110.1
AFP36734.1 (+1)
AFP38548.1 (+1)
AIU10799.1

47 kDa
30 kDa
26 kDa
10 kDa

95% (INF)
95% (INF)
95% (INF)
95% (INF)

AIU10299.1 (+1)
AFP42711.1

41 kDa
34 kDa

95% (INF)
95% (13)

5EQD_A (+2)
AFP40119.1 (+1)
AFP42669.1 (+1)

46 kDa
31 kDa
13 kDa

95% (5.1)
95% (2.8)
95% (2.4)

WP_003897810.1

34 kDa

95% (2.4)

AFP41837.1 (+1)
AFP41316.1

51 kDa
48 kDa

95% (2.2)
95% (2.0)

Table A2. Proteins enriched in the IMD under starvation.
Highlighted in green are the proteins found previously in the IMD and in orange the
ones found in the PM-CW (Hayashi et al, 2016).
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A

B

Figure A1. Proteome of the IMD under stress.
Functional annotation of proteins found in the IMD during log phase (A) and under
6 hours starvation (B).
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APPENDIX B
SUBCELLULAR LOCALIZATION OF MTRAB SYSTEM
Analyzing the proteome of the IMD under starvation described above, we
detected the enrichment of MtrA, although it did not pass the cut-off against the wild
type (see Appendix A). MtrA is the response regulator part of the MtrA/MtrB two
component regulatory system, which is conserved in mycobacteria and is the only
known essential two-component system in M. tuberculosis (Zahrt and Deretic,
2000). In this microorganism, MtrA is involved in the expression regulation of
several genes, including itself, promoting a positive feedback, and oriC and dnaA,
which are essential for replication initiation (Rajagopalan et al, 2010; Purushotham
et al, 2015; Greendyke et al, 2002). MtrB is the sensor kinase of this system, and its
ability to autophosphorylate and further activate MtrA is dependent on its
localization at the septum in M. tuberculosis (Plocinska et al, 2012; 2014). MtrA is
thought to interact and stabilize DnaA. When the ratio between phosphorylated
MtrA (MtrA~) to MtrA is elevated dnaA and dnaN transcription are repressed and
expression of other genes involved in septum formation are activated (Purushotham
et al, 2015). Therefore, the balance between MtrA and MtrA~P in the cell is
necessary for optimal proliferation (Fol et al, 2006; Rajagopalan et al, 2010).
In a paper published by Betts et al (2002) the gene and protein expression
levels of M. tuberculosis were measured under a nutrient starvation model similar to
ours (see Appendix A). In their results we can observe that MtrA was upregulated at
24 hours starvation, whereas MtrB was downregulated after 4 hours starvation. Our
results showed MtrA enrichment in the IMD with a 42-fold change when compared
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to the IMD in log phase. We hypothesize that during log phase MtrA can be
associated with MtrB at the septum but is sequestered to the IMD during nutrient
starvation.
To test this hypothesis, we first performed a sucrose gradient fractionation
with cells expressing MtrA-Dendra2-FLAG and MtrB-Dendra2-FLAG to determine
their subcellular localization under growing conditions. Interestingly, we detected
both proteins in fractions 2 and 3 (Fig B1). PimB’ designates the IMD fractions. After
6 hours of starvation, however, both proteins were relocated mostly to fraction 3
and overlapping with the IMD fraction 4 (Fig B1). Detailed protocols are found in
the Laboratory Notebook Puffal #9, Pages 86-87, 94-97, 100-107.
To investigate this change in localization, we decided to perform a
shallower sucrose gradient, from 15 to 30% sucrose, instead of our established
condition, 20-50%. The IMD fractions on this gradient were determined by the
detection of PimB’ in fractions 5-10 (Fig B2). We could see that both MtrA and MtrB
move from fractions 1 and 2 upon starvation, localizing to fractions 3-6, again
starting to overlap with the IMD. However, this experiment was done only once and
the reproducibility of these data is not yet confirmed. Detailed protocols are found
in the Laboratory Notebook Puffal #10, pages 117-131.
Discussion
In this section I demonstrate the dynamic localization of MtrAB system. The
fact that the proteins cannot be detected in fraction 1 under starvation, may suggest
their sequestration from the cytosol under starvation. During this kind of stress,
mycobacteria is known to form long septated cells that might contain several
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chromosomes before being able to divide (Li et al 2010; Wu et al, 2016). With the
knowledge that MtrA is activated in the septum by MtrB, the notion that these
proteins are concentrated at the septa when the cells are under starvation is
appealing. Furthermore, it looks like part of these protein pool relocalize to the IMD
when cells are not proliferating, perhaps because of the proximity of this membrane
domain from the septa.
This novel pattern of localization to earlier fractions of the gradient is
intriguing and might suggest a new membrane domain within M. smegmatis.
Unfortunately, I was unable to immunoprecipitate MtrB or pellet by differential
centrifugation to detect other proteins interacting with this potential novel
membrane (detailed results are found in the Notebook Puffal #10, pages 86-89, 140145; #11, pages 12-25, 29-31, 40-45, 48-61, 66-67). Further studies are currently
under investigation in the Morita lab.
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Figure B1. MtrAB subcellular localization.
MtrA (49 kDa) and MtrB (83 kDa) localization during log phase detected by antiFLAG antibody, in fractions 2 and 3. PimB’ designates the IMD fractions. Under
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APPENDIX C
PHAGE SHOCK PROTEIN (PSP) SYSTEM AND MEMBRANE STRESS RESPONSE
The Psp system is widely conserved in bacteria and it is known to be
activated by membrane damage (Joly et al, 2010; Flores- Kim and Darwin 2016;
Manganelli and Gennaro 2017). In M. tuberculosis, this protein complex is proposed
to have an envelope-stabilizing function similar to that observed in Gram-negative
bacteria (Provvedi et al,2009; Datta et al, 2015). Previous work demonstrated that
dissociation of PspA from the transcription regulator ClgR requires the presence of
the integral membrane protein PspM (Datta et al, 2015). It was also shown that
PspA and PspM interact forming a membrane complex upon stress (Mawuenyega et
al, 2005; Datta et al, 2015, White et al, 2011), suggesting that this system have an
envelope-preserving function. In collaboration with the Gennaro Lab (Rutgers
University), we determined whether the Psp multiprotein complex localizes to the
mycobacterial membrane during stress.
For this experiment, we used wild type M. smegmatis and M. smegmatis
ΔpspM (provided by the Gennaro Lab), grew the cells to log phase (OD600 0.5-1.0)
and performed sucrose density gradient fractionation after lysing the cells with
nitrogen cavitation. This was done in two biological replicates. We also subjected
these strains to two different membrane stress by adding 0.02% SDS to log phase
cells (OD600 0.5-1.0) for 6 hours or 0.03% SDS for 20 hours, growing the cells to an
OD600 of 0.6 and diluting the cultures to an OD600 of 0.3 prior to addition of SDS.
After lysis and density fractionation, we ensured the gradient formation by
analyzing the refractometer index and, through western blot, detected PimB’ as the
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IMD marker, and MptA and MptC as the PM-CW markers. We used anti-PspA
antibody provided by the Gennaro lab to determine its localization within the
gradient under log growth phase or stress conditions.
In the first experiment, during log phase, we observed the PspA subcellular
localization in M. smegmatis wild-type to the IMD, co-localizing with PimB’, but also
to the cytosolic fraction (Fraction 1; Fig C1). The cytosolic PspA detection was not
reproducible (as seen in Figure C2A). M. smegmatis ΔpspM had similar PspA
localization in log phase, but this protein wasn’t detected in the cytosolic fraction
(Fig C1). Under the membrane stress using 0.02% SDS for 6 hours, in both cell lines
PspA was maintained in the IMD, with no detection of it in the PM-CW fractions (912) (Fig C1). Detailed protocols are found in the Laboratory Notebook Puffal #11,
pages 132-138, 142-145.
When performing the second biological replicate during log phase, we
detected PspA in the IMD, but not in the cytosol, as seen by the colocalization with
PimB’ to fractions 4 and 5 in both cell lines (Fig C2AB). The PM-CW markers MptA
and MptC extend across the denser fractions of the gradient (Fig C2AB). After 20
hours of SDS stress, PspA seems to also localize to the later fractions of the gradient
in wild type cells, presumably the PM-CW fractions (Fig C2C). In the absence of
PspM, however, PspA localized mainly to fraction 1, deemed to be the cytoplasmic
fraction (Fig C2D). The IMD marker PimB’, however, was not detected in its
designated fractions 4-5 after the stress in either cell line (Fig C2CD). We were also
unable to detect the PM-CW marker MptA, and MptC showed more broad
localization after stress (Fig C2CD). These unusual distribution patterns of the
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endogenous markers are possibly because of the prolonged membrane stress
impacting on protein abundance and specific localization. To assess the change in
protein abundance, we detected both PimB’ and MptA on the crude lysate via
western blot. The overall detection of PimB’ was seemingly similar when the
different conditions were tested, but the level of MptA after stress was severely
decreased, likely due to degradation (Fig C3). Detailed protocols are found in the
Laboratory Notebook Puffal #15, pages 14-15, 20-25, 42-43, 50-55, 130-134, 112123.
Notably, for the wild-type, the initial OD600 = 0.80 for the short stress was
increased to OD600 = 1.05 at the end of the 6 hours treatment. When stressed for 20
hours, the initial OD600 = 0.36 did not change significantly, staying at an OD600 = 0.42.
The Gennaro lab also observed that NADH dehydrogenase type II (NDH-2)
inhibitors (thioridazine, THD; clofazimine, CFZ) susceptibility was increased when
both pspAM were deleted. Deletion of pspM alone had no effect on the bactericidal
activity of these of the compounds. This increased susceptibility suggested a
selective NDH-2 defect in this mutant. They determined that the NDH-2 protein
abundance in whole cell lysates of the ΔpspAM mutant was lower than wild type.
Based on these observations, we analyzed the subcellular localization of this protein
in M. smegmatis wild type, ΔpspM and ΔpspAM mutants expressing Ndh2-6xHis
(SUMA454, SUMA453, SUMA452).
We performed nitrogen cavitation and sucrose density fractionation of each
of the cell lines in two biological replicates, and detected Ndh2-6xHis using anti-His
antibody. In the first experiment, NDH-2 was consistently localizing to the IMD (Fig
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C4A). The localization to the PM-CW was also observed in wild-type and ΔpspM
strains, but it was barely detectable when both PspAM were deleted (Fig C4A). It can
also be observed that in wild-type the distribution of NDH-2 seems to be more
evenly than when PspM is deleted (Fig C4A). Detailed protocols are found in the
Laboratory Notebook Puffal #13 pages 120, 128-133.
The gradients of the second biologic replicates were properly formed as
shown by the increased density revealed by refractometer index (Fig C4B). The IMD
and PM-CW markers, PimB’ and MptA respectively, were localized to their
designated fractions. As seen above, PspA also localized to the IMD (Fig C4B). In all
cases NDH-2 was mainly localizing to the IMD and in less abundance to the PM-CW
(Fig C4B). Detailed protocols are found in the Laboratory Notebook Puffal #15,
pages 44-45, 88-91, 96-103, 118-127.
Discussion
Here we revealed the dynamic subcellular localization of PspA under
membrane stress. We also demonstrated that the different types of stress, using
0.03% SDS for 20 hours or 0.02% SDS for 6 hours, had different effects on the
strains tested. First, the longer stress caused the cells to enter a bacteriostatic state,
which was not observed as evidently by the 6 hours stress with lower dosage of SDS.
These observations can explain the discrepancy on the PspA localization pattern
observed between both experiments. While the shorter stress with lower SDS
dosage did not affect the PspA localization, the longer stress cause PspA to associate
with the PM-CW in wild type and released to the cytosol in ΔpspM. These data
suggest that upon stress PspA re-localizes, likely to interact with PspM in the
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membrane. When PspM is not present, PspA mislocalizes to the cytosol. These
results link membrane preservation functions with the IMD in M. smegmatis. Our
collaborators also demonstrated the induction of PspA under stress in wild type but
not in the absence of PspM. Therefore, PspM is required for PspA induction by
envelope stress but not for PspA association with the IMD. The close proximity of
the IMD to the growing pole of the cell could favor the concentration of important
maintenance proteins, such as PspA, to stabilize the membrane upon stress.
This is the first example of stress-induced membrane protein redistribution
where the IMD and PM-CW markers are affected in the sucrose gradient. We have
previously shown that under starvation or antibiotic stress the IMD is re-distributed
in live cells, going from the poles to the column of the cell (Hayashi et al, 2018), but
the detection of IMD markers was possible in fractions 4 and 5 of the gradient,
consistent with what is observed in growing cells. The nature of the membrane
stress tested here could potentially affect more severally the membrane
organization and protein association to the IMD. It will be interesting to investigate
more about this kind of stress and determine if other proteins associated with the
IMD have similar behavior on a sucrose gradient.
Being part of respiratory chain in mycobacteria it makes sense for NDH-2 to
be present in the plasma membrane. However, to be properly active it should be
located in the PM-CW, where other respiratory chain enzymes can be found
(Hayashi et al, 2016). Although varying between biological replicates, we observed
the localization NDH-2 consistently in the IMD with less reproducible detection in
the PM-CW. The localization of this protein in the IMD might suggest that NDH-2 can
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be found in two forms: active and non-active. Our collaborators observed reduced
levels of NDH-2 when both PspAM are deleted, perhaps affecting the reproducibility
of detection of this protein within the gradient fractionation. They also found that
the NDH-2 enzymatic activity was reduced in mutant cells. The observation that the
deletion of both pspAM, but not only pspM, can affect the susceptibility of NDH-2
inhibitors can be potentially interesting in dissecting a different role for the PspA.
Perhaps PspA can facilitate the translocation of NDH-2 from the IMD to the PM-CW.
It will be interesting to see the activity of this protein in the IMD versus the PM-CW.

138

M. smegmatis ΔpspM
Log phase

M. smegmatis WT
Log phase
kDa
37
25

1

2

3

4

5

6

7 8

9 10 11 12

*

50

PspA
PimB’

37

kDa
37
25

1

2

3

4

6

7 8

9 10 11 12

*

50

PspA
PimB’

37
Cytosol

IMD

PM-CW

Cytosol

MD

SDS stress
kDa
37

5

1

2

3

4

5

6

7 8

PM-CW

SDS stress
9 10 11 12
PspA

25
50

PimB’

37

kDa
37

1

2

3

4

5

6

7 8

9 10 11 12

*

25
50

PimB’

37
Cytosol

IMD

Cytosol

PM-CW

PspA

IMD

PM-CW

Figure C1. PspA localization under 0.02% SDS stress.
M. smegmatis wild-type and ΔpspM mutant lysates were analyzed during log phase
and after membrane stress with 0.02% SDS for 6 hours. PspA (30 kDa) detected in
the IMD fractions during log phase in both cell lines, and detection of PspA in the
cytosol (fraction 1) of wild-type. PimB’ (41 kDa) is the IMD marker. After SDS stress
PspA detected in the IMD fractions as well. *, non-specific bands.
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Figure C2. PspA subcellular localization.
During log phase, sucrose gradient density fractionation show PspA (30 kDA)
detected in the IMD of (A) wild-type M. smegmatis and (B) M. smegmatis ΔpspM. The
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MptA shows levels decrease upon stress in both strains.
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Figure C4. NDH-2 subcellular localization.
(B) Detection of NDH-2 subcellular localization in the first biological replicate of M.
smegmatis wild type, ΔpspM and ΔpspAM. (A) Sucrose density fractionation of
second biological replicate of M. smegmatis wild type, ΔpspM and ΔpspAM. Sucrose
density show proper formation of the gradients. Ndh2 (50 kDa) was detected using
anti-His antibody. PspA (30 kDa), IMD marker PimB’ (41 kDa) and PM-CW marker
MptA (54 kDa) were detected on each gradient.
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APPENDIX D
MANNOSE METABOLISM
The mycobacterial plasma membrane is composed of major phospholipids
such as phosphatidylinositol (PI) and phosphatidylinositol mannosides (PIMs). The
biosynthesis of the latter starts with PI and step-by-step mannose additions lead to
the final products acylated (Ac)PIM2 and AcPIM6 as well as lipomannan (LM) and
lipoarabinomannan (LAM). We have previously demonstrated that this biosynthesis
starts in the IMD and more polar products such as AcPIM6, LM and LAM are
synthesized in the PM-CW (Morita et al, 2005; Hayashi et al, 2016; Sena et al, 2010).
The enzymes responsible for the addition of mannose utilize polyprenol mannose
and GDP-mannose as donors in the IMD and PM-CW respectively.
To observe the mannose metabolism, we utilized [3H]mannose and evaluated
its incorporation. Using M. smegmatis expressing GlfT2-HA, we incubated the cells
with 50 µCi/ml [3H]mannose for 15 min, washed and chased with non-radiolabeled
1 mM mannose. At time points 0, 0.5, and 3 h we harvested the cells, performed
bead-beating and immunoprecipitation (IP) to pull down the IMD. The samples
were subjected to butanol partitioning, and lipids were resolved on high
performance thin layer chromatography (HPTLC) silica gel in
chloroform/methanol/13 M ammonia/1 M ammonium acetate/water
(180:140:9:9:23, v/v) and visualized by fluorography using En3Hance.
First, to ensure the [3H]mannose incorporation, we performed a pulse-chase
with the crude lysate. As shown in Figure D1, the mannose was incorporated over
time, forming PIM species in wild type (WT). At 6 hours, we observed that only the
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final products were remaining, so we decided to proceed with the next experiment
for 3 hours.
Next, we also optimized the bead-beating lysate and IP. We grew M.
smegmatis expressing GlfT2-HA (SAB568) strain to log phase and tested beadbeading lysis with standard glass beads used in the lab (Sigma, G4649) and
zirconium beads (Benchmark Scientific) of different sizes: 0.5, 1.5, 3.0 mm, and a
mixture of them. We determined the protein concentration by BCA assay as well as
cell survival by inoculating serial dilutions after the lysis. The protein concentration
did not change significantly when different beads were used, ranging from 5-7
mg/ml (Table D1). For survival analysis we diluted the lysate to 109 and inoculated
dilutions 10-7 to 10-9 into 7H10 plates. No colonies grew to those dilution for the
glass beads or zirconium 1.5 mm, but colonies were observed to 10-8 after lysis with
zirconium 0.5 and 3.0 mm, and the mixed beads (Table D1). We performed IP using
anti-HA agarose beads with all the lysates. GlfT2-HA was detected in all samples (Fig
D2). MptA, a PM-CW marker, and PimB’, IMD marker, were also detected in input
samples. Being an IMD-associated protein, we expected PimB’ to be pulled down if
the IP was successful. As seen in Fig 2, we better detected PimB’ in the IP done after
the bead-beating by 0.5 mm zirconium beads. The detailed protocols are found in
the Laboratory Notebook Puffal #3 pages 116-117, 120-124, 128-131.
After these optimization procedures, we went ahead and performed the
pulse-chase experiment with [3H]mannose followed by bead-beading and IP of the
IMD. In Figure D3, we show the incorporation of the [3H]mannose over-time in
whole cell lysate and in the IMD. The aqueous phase in the crude lysate show the
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presence of overflow [3H]mannose, while in the organic phase we can see the
incorporation of the molecule at 0 h and end products accumulating at 3 hours of
chasing (Figure D3). In the IMD, the lipids were extracted after
immunoprecipitation, and we see a slower incorporation of the [3H]mannose
(Figure D3). At 3 hours, there is the presence again of the final products AcPIM2 and
AcPIM6. The detailed protocols are found in the Laboratory Notebook Puffal #4
pages 82-87.
Discussion
Previous data show that AcPIM2 is formed in the IMD, by the action of PimB’,
while the later product AcPIM6 is formed by PimE in the PM-CW (Morita et al, 2005;
Hayashi et al, 2016). Here we demonstrated the presence of radiolabeled lipids in
the IMD, with an accumulation overtime. We expected to see a transient
incorporation of the [3H]mannose in the IMD, with mainly AcPIM2 being present.
However, we saw the presence of AcPIM6 in the IMD as well. This suggests that the
PM-CW and IMD have a dynamic fluidity, and lipids made in one domain can transit
to another. For a better understanding of this dynamism, a longer chase could be
suggested.
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Figure D1. [3H]mannose incorporation in crude lysate of M. smegmatis.
PIMs species can be seen, with intermediate species showing rapidly while the final
products AcPIM2 and AcPIM6 are accumulating at 6 hrs for wild-type (WT).
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Glass

Protein conc.
(mg/ml)
6.701

Z mix

6.466

Z 0.5

6.537

Z 1.5

5.759

Z3

5.199

Beads

Serial dilution

Colonies

10-7
10-8
10-9
10-7
10-8
10-9
10-7
10-8
10-9
10-7
10-8
10-9
10-7
10-8
10-9

0
0
0
10
3
0
160
10
0
0
0
0
50
4
0

Table D1. Optimization of bead-beating.
Glass beads were tested versus zirconium (Z) beads with 0.5, 1.5 and 3 mm
diameter. Protein concentration was measured by BCA assay after lysis and colonies
counted after serial dilution of lysate.
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Figure D2. Immunoprecipitation of GlfT2-HA.
Different lysates of M. smegmatis expressing GlfT-2 were immunoprecipitated using
anti-HA beads. Detection of HA, MptA and PimB’ from input, immunoprecipitation
with HES buffer and with detergent (HESD).
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Figure D3. Mannose metabolism in crude lysate and in the IMD.
The incorporation of [3H]mannose was effective in the crude lysate and in the IMD.
Accumulation of final PIMs species can be seen at 3 hours in both cases.
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APPENDIX E
MENAQUINONE DETECTION
Studying the menaquinone biosynthetic reaction, we sought to detect the
final product of these reactions, menaquinone-9 (MK-9), using high performance
thin layer chromatography (HPTLC). First, we attempted to detect MK-9 by whole
cell labeling using L-[methyl-14C]-methionine. For this experiment, we used M.
smegmatis wild-type and a cell line expressing MenG with an HA-epitope tag
described on Chapter 2. We also used a known MenA inhibitor, Ro48-8070,
previously described (Dhiman et al, 2009). The lipids were extracted 0.5, 2 and 6
hours after incubation with L-[methyl-14C]-methionine, with and without Ro488070 treatment. The lipids were resolved on HPTLC silica gel in hexanes/diethyl
ether (80:20) and visualized by fluorography using En3Hance. In both cell lines, the
MenA inhibition after 0.5, 2 or 6 hours caused a band to disappear, suggesting the
inhibition of MK-9 formation (Fig. E.1). Detailed protocols are found in Laboratory
Notebook Puffal #6, pages 64-65.
To investigate if this band was also affected when the MenG dual-switch
anhydrotetracycline (ATC)-inducible knockdown M. smegmatis strain, described on
Chapter 2, was used. We depleted MenG by adding ATC to the inoculum and
performed lipid purification after 96 hours depletion. The lipids were resolved and
visualized as described above. The band pattern visualized with and without MenG
depletion was similar to each other, suggesting that the L-[methyl-14C]-methionine
incorporation was still happening upon MenG depletion (Fig. E.2). Detailed
protocols are found in Laboratory Notebook Puffal #12, pages 18-19.
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Using a different approach, we used commercially available menaquinone-4
(MK-4) and MK-9 as standards to compare migration patterns of the lipids purified.
We performed lipid extraction from log phase strains expressing MenA and MenG
HA tagged mentioned on Chapter 2, plus wild type, and developed the purified lipids
on HPTLC silica gel in hexanes/diethyl ether (80:20), and visualized with cupric
acetate. We observed the pattern of migration of MK-9 and similar bands were
detected in all strains tested (Fig E.3). Detailed protocols are found in Laboratory
Notebook Puffal #10, page 150, and #11, pages 26-27.
Next, we examined if the same migration pattern could be detected on
fractions of a sucrose density. Using the MenG dual-switch ATC-inducible
knockdown, we performed lipid extraction of sucrose gradient fractions with and
without ATC treatment, and developed on TLC as described above. The same band
of MK-9 was detected evenly distributed along the fractions of the gradient prior to
MenG depletion. Interestingly, this band pattern was weakened in the latter
fractions of the gradient after ATC treatment. Another observation was the
enrichment of a lower band along the fractions after MenG depletion (Fig. E.4).
Detailed protocols are found in Laboratory Notebook Puffal #12, pages 12-13.
Discussion
The radiolabeling assays using L-[methyl-14C]-methionine were helpful
when MenA was inhibited. This inhibition prevents demethylmenaquinone (DMK)-9
formation, which has been shown to be lethal in M. smegmatis (Dhiman et al, 2009).
The disappearance of a band after MenA inhibition can suggest that that was the
final product MK-9. However, when our MenG inducible knockdown strain was
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used, we could not detect the disappearance of a band. This may suggest that MK-9
made before the enzyme was shut off might remain present for a longer period of
time.
The approach using cupric acetate for the lipid detection on HPTLC allowed
us to compare the banding pattern with the commercially available MK-9. A band
with the same migration was observed in all strains tested suggesting MK-9
detection. Additionally, we observed the same band on all fractions of a gradient
fractionation, with consistent intensity along the fractions. The observation that this
band was still present when MenG was depleted is consistent with the radiolabeling
assay. Interestingly, we noticed a re-distribution of MK-9 when ATC was present,
and a higher intensity of a lower band after the treatment, agreeing with the data
showed on Chapter 2 that MK-9 is still present, with an accumulation of DMK-9,
possibly shown by this lower band.
Because these data were inconclusive, we did mass spectrometry analysis to
detect and quantify the menaquinone species as described on Chapter 2.
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Figure E.1. Menaquinone-9 detection after MenA inhibition.
Wild-type and MenG-expressing strains were treated with MenA inhibitor and lipids
purified and developed with hexanes/diethyl ether (80:20) on TLC plate exposed to
En3Hance.
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Figure E.2. Menaquinone-9 detection after MenG depletion.
M. smegmatis expressing MenG with a dual-switch ATC-inducible knockdown was
treated with ATC for 96 hours. Lipids were purified and developed with
hexanes/diethyl ether (80:20) on TLC plate exposed to En3Hance.
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Figure E.3. Menaquinone detection on crude lysates.
Lipids from strains expressing HA-tagged MenA, MenG, and wild-type (WT) were
developed with hexanes/diethyl ether (80:20) on TLC plate stained with cupric
acetate. Menaquinone-4 (MK4) and -9 (MK9) used as controls.
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Figure E.4. Menaquinone-9 detection of sucrose gradient fractions.
Lipid extraction of sucrose gradient fractions (1-12) before and after MenG
depletion (ATC - and ATC +) were developed with hexanes/diethyl ether (80:20) on
TLC plate stained with cupric acetate.
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